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1 Introduction 
European Union (EU) requests standards for veterinary public health and food safety in both 
operative procedures and official controls as stated in “White Paper on Food Safety” (COM, 
1999, 719) and in regulation EC No 882/2004. These standards define the mandatory 
requirement and objectives for Nations within the EU. Furthermore, Standard Operating 
Procedures (SOPs) for Competent Authorities should be adopted in order to encounter EU 
requisites. To satisfy these specific aspects on food safety and veterinary public health, 
Lombardy regional government and the Department of Veterinary Science and Public Health 
(DIVET) of University of Milan initiated a shared initiative to develop a three-year program 
aiming to improve efficiency, efficacy and quality of the regional veterinary services. One of the 
tasks of this project was the development of a scoring model for risk-characterization and 
prioritisation concerning relevant diseases for human and animal health. This model had to take 
into account not only the specific characteristics of the diseases but also the geographic 
background of application (Lombardy region). Moreover, the scoring model had to be based on 
an accurate definition of the hazards and the related risks in order to provide a reliable risk-based 
tool for prioritisation in public health. 
 
1.1 Definitions 
In 1995, The World Health Organization (WHO) and the Food and Agriculture Organization of 
the United Nations (FAO) developed a manual on risk-based approaches for the management of 
public health hazards in food (1). In this manual and its further updates (2), FAO and WHO, 
through the Codex Alimentarius Commission (CAC), dictated the guidelines for risk analysis 
and the related definitions. 
Figure 1 shows the framework of risk analysis and how risk assessment, risk management and 
risk communication should work together, as depicted in (1, 3). 
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Figure 1 − Risk analysis framework (1, 3). 
 
HAZARD: a biological, chemical, or physical agent that may have an adverse health effect (1).  
RISK: a function of the probability of an adverse effect and the magnitude of that effect, 
consequential to a hazard (1). 
RISK ANALYSIS: a process consisting of three components: risk assessment, risk management 
and risk communication (see Figure 1) (1).  
RISK ASSESSMENT: the scientific evaluation of known or potential adverse health effects 
resulting from human exposure to hazards. The process consists of the following steps: hazard 
identification, hazard characterization, exposure assessment, and risk characterization. The 
definition includes quantitative risk assessment, which emphasizes reliance on numerical 
expressions of risk, and also qualitative expressions of risk, as well as an indication of the 
attendant uncertainties (1, 3-5). 
− Hazard identification: the identification of known or potential health effects associated 
with a particular agent (1). 
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− Hazard characterisation: the qualitative and/or quantitative evaluation of the nature of 
the adverse effects associated with biological, chemical, and physical agents which may 
be present in food. For chemical agents, a dose-response assessment should be 
performed. For biological or physical agents, a dose-response assessment should be 
performed if the data is obtainable (1). This definition can also be adopted in veterinary 
public health for hazard characterization of infectious diseases. 
− Exposure assessment: the qualitative and/or quantitative evaluation of the degree of 
intake likely to occur (1). 
− Risk characterisation: integration of hazard identification, hazard characterization and 
exposure assessment into an estimation of the adverse effects likely to occur in a given 
population, including attendant uncertainties (1). 
RISK MANAGEMENT: the process of weighing policy alternatives to accept, minimize or 
reduce assessed risks and to select and implement appropriate options. The risk management 
follows four step (1, 3-6): 
− Preliminary risk management activities: preliminary risk profile and gathering of 
known information. 
− Evaluation of risk management options: analysis of available system of control; 
resources and cost-benefit investigation. 
− Implementation of the risk management decision: laws, regulation, controls and on-
going verification.  
− Monitoring and review: process that involves continue gathering and analysing of data 
and verifies control plans and the progress in risk management. 
RISK COMMUNICATION: An interactive process of exchange of information and opinion on 
risk among risk assessors, risk managers, and other interested parties (5, 7). 
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1.2 Geographical Background: Lombardy region 
Lombardy is an Italian region situated in the north of the nation and is bordered by Switzerland 
(north), Emilia-Romagna region (south), Piedmont region (west), Trentino-Alto Adige region 
(east), and Veneto region (east). Lombardy region, with its 9,990,604 inhabitants (8), has the 
largest population among Italy regions. 
Lombardy is the major contributor to Italian Gross Domestic Product (GDP) in terms of agro-
food production. Indeed, as reported by Regional Government Statistics, agronomic industry has 
a value of over 6.35 billion euros, and 70,916 farms are present within the region (9). 
Numerically, the most represented livestock are poultry (over 27 millions), swine (5.16 millions) 
and bovine (1.5 millions). However, when the share of regional contribution to the national 
output is considered, swine meat represents 40% of the total, milk production 37%, bovine meat 
26%, poultry meat 19% and egg production 17.7% (10). Moreover, Lombardy exports, related to 
livestock industry, represent almost a third of all Italian exportations in the sector. Specifically, 
about 70% of these trades are with EU countries (value of 1,572 million of euros) and the 
remaining 30% with countries outside EU (value of 723 million of euros) (11). 
Food industry is well-developed too, with an output value of 5.2 billion (9). In Lombardy there 
are over 63,000 plants for production, transformation, or trade of foods of animal origin and 
2,739 of these plants are certificated at EU-level. These latters establishment employ over 28,000 
people (11). Furthermore, the average number of employee for plants that work only at national 
level is 6.9 while plants certificated at EU-level have 49.4 employee on average (11). 
These data emphasize, if needed, the strategic value of agronomic and food industries and, 
therefore, the importance of zoonosis control and food safety in the region. 
Table 1 summarises the official status of animal diseases, in Lombardy, reported by Regional 
Government Statistics (9, 11). 
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Bovine 
Disease Official status Frequency of the disease 
Bovine tuberculosis Free. Sporadic (5 outbreaks in 2012, 4 in 
2013). 
Bovine brucellosis Free. Sporadic to none (less than 1 
outbreak per year). 
Enzootic bovine leucosis Free. None. 
Blue tongue Free. None. 
Paratuberculosis Not free (novel official control plan, 
DDGN N°6845 del 18/07/2013). 
About 70% of prevalence at farm-
level.  
Bovine spongiform encephalopathy 
(BSE) 
Free. None (last positive case in 2011, a 
14-years old cow). 
Infectious bovine rhinotracheitis 
(IBR) 
Not free (1,699 farms with official 
free status). 
36.50% of prevalence at farm-level 
(serological surveillance). 
Mastitis (S. agalactiae) Not free (about 4,000 farms 
considered free). 
12 – 15% of prevalence at farm-
level (spot-check surveillance). 
   
Small ruminants 
Disease Official status Frequency of the disease  
Brucellosis (small rum.) Free. None. 
Blue tongue Free. None. 
Transmissible spongiform 
encephalopathy (small rum. TSE) 
Not free. Sporadic (17 outbreaks from 2003 to 
2013). 
Contagious agalactia Not free. Sporadic (15 outbreaks from 2009 to 
2012). 
   
Swine 
Disease Official status Frequency of the disease  
Aujeszky’s disease Not free. 21 – 27% of prevalence at farm-
level. 
Classic swine fever Free. None. 
Swine vesicular disease Free. None. 
   
Poultry 
Disease Official status Frequency of the disease  
Avian influenza Not free. Sporadic (7 outbreaks of H5N2 in 
2012, 1 of H5N3 in 2013). 
Salmonellosis (S. Enteritidis, S. 
Thyphimurium)  
Not free. Chickens: 5.92% (2012) – 1.42% 
(2013) at animal-level. 
Parents: 1.71% (2011) –  0% 
(2012/13). 
Broilers: 2.7% (2011) – 0.61% 
(2013). 
Turkeys: 0% (2011) – 1.03% (2013) 
   
Others 
Disease Official status Frequency of the disease  
Rabies Free. None. 
West Nile fever Not free. Spot-check surveillance, 2013: 
Insects: 152 controls, 7 positives. 
Horses: 440 controls, 5 clinical 
cases and 6 seropositives. 
Synanthropic birds: 756 controls,  2 
positives (crows). 
Table 1 – Regional Government Statistics on animal diseases.  
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1.3 Setting priorities in public health 
Several Countries allocate a large amount of human and financial resources to public health. 
However, these assets are not unlimited, especially in case of veterinary public health, therefore, 
setting priorities for rational allocation of available resources is pivotal. In addition, health risks 
are subject to relevant changes over time, and thus, primary targets and surveillance programs 
should be reviewed periodically (12). 
Various scoring model for prioritisation were developed during the last decades and they were 
based on different methods. In the specific field of public health, three approaches shows 
particular usefulness: multiple-criteria decision analysis (MCDA) (13-16), consensus processes 
(12, 17, 18), and expert frameworks (17, 19-21). Among these approaches, consensus processes 
can be effective methods when scientific data is absent, insufficient or contradictory (12); in 
public health and healthcare the most frequently applied processes is the Delphi protocol. 
The Delphi protocol is a consensus process extensively used in very different fields. This 
protocol was developed initially for business, industry management, and government. 
Nevertheless, the Delphi technique is also applicable in other fields such as healthcare science 
(22, 23), veterinary science (24, 25), and public health (26). Furthermore, a recent method, 
named Formalized Consensus Process (FCP), was developed specifically for healthcare and 
public health (27). 
 
1.3.1 Delphi Protocol 
The Delphi protocol is a structured process developed to provide a systematic method for 
reaching consensus among a group of experts. This protocol can be suitable for the following 
major objectives (28): 
− To assess information which may lead to differing judgements; 
− To collect information which may produce a consensus of the group; 
− To integrate judgements on issues that encompass a wide range of disciplines; 
− To instruct the group about different and interrelated aspects of the problems. 
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The Delphi method involves several progressive steps that can be summarised as (22): 
1. Identification of the problem. 
2. Selection of the expert panel: during this phase is selected a group of several 
individuals with specific expertise about the problem under analysis. 
3. First round: during this step opinions of the experts, regarding the issue under 
assessment, are collected. These statements are gathered in a specific questionnaire and, 
finally, the questionnaire is submitted to each participants. 
4. Second round: experts score their degree of agreement with every statement in the 
questionnaire, these ranks are summarised and integrated with the questionnaire. 
5. Third round (repeatable): experts re-score their agreement with every statement in the 
questionnaire, during this phase is possible to review the scoring in light of the second 
round results. 
6. Analysis of results: round results are analysed to establish the degree of consensus, if the 
consensus is not reached the third round must be repeated until agreement among experts 
is fulfilled. 
7. Final report: a document that gather the results of the process (finalised statements, 
guidelines, prioritisation models, etc.) and accurately recap the previous steps is 
produced. 
A facilitator supervises the entire process, this individual provides assistance to the experts 
(collection of answers, feedbacks, statements, etc.) and manages the various steps of the 
protocol.  
One of the “core” feature of the Delphi protocol is anonymously, indeed, responses and 
commentary during rounds are strictly anonymous in order to avoid domination of the process by 
one or few participants (29). Additionally, criteria that defines consensus among the experts 
should be clearly identified and reported before the beginning of the process itself (30). 
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1.3.2 Formalized Consensus Process 
Formalized Consensus Process is a method of consensus developed by the Haute Autorité de 
Santé (HAS), a French Independent Administrative Authority (Autorités Administratives 
Indépendante – AAI). HAS published the initial FCP guidelines during the 2006 (31) and an 
update in 2010 (27).  
The main objectives of FCP are to formalize agreement between experts and to identify and 
select the best practices. Using the FCP can be considered if at least two of the following 
conditions are met (27): 
− Insufficient literature sources regarding specific questions or problems; 
− An independent expert panel witch need to select appropriate solutions of different issues 
from several alternatives; 
− Topics or clinical conditions easily identifiable. 
Development of FCP follows five phases such as (27): 
1. Systematic review and synthesis of literature: this step starts with the identification of 
scientific topics and keywords to comprise in the search. Moreover, criteria for the 
inclusion/exclusion of scientific papers (e.g. English-written and peer-reviewed) must be 
defined a priori. Finally, a critique analysis of search results must be performed in order 
to establish the degree of pertinence of the papers. 
2. Assessment of issues: a group of experts provides a selection of issues and proposal 
which will be analysed. Specifically, this phase comprises two round of analysis; an 
intermediate feedback meeting has also to be performed. During the assessment of issues, 
points of agreement, disagreement or indecision are discussed too. 
3. Initial proposals: the purpose of this step is to write the first draft of recommendations 
and proposals that the expert panel will further discuss and review. 
4. Discussion and improvement of proposals: during this phase the original version of 
recommendations and proposals are reviewed, in particular their acceptability, 
applicability and readability. Furthermore, all the quotes and comments of the group of 
experts are collected and used to improve the initial draft. 
5. Finalisation: this phase produces a series of documents which encompasses all the 
recommendation, scientific argument and final models shaped during the process.   
A facilitator (as an individual or a group) follows the entire process and provide a role 
comparable to the facilitator of the Delphi methods. 
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1.4 Scoring systems for veterinary public health 
Despite the availability of consolidated methods, such as consensus processes and MCDA, 
scoring systems for prioritisation and risk characterisation in veterinary public health are still 
poorly available. Moreover, available systems are usually based on expert frameworks. 
During the last 15 years, different tools for prioritisation in animal health were developed. These 
systems had different focus, depending on their objectives, and they are reviewed in (17). 
Among these models, three scoring systems were settled to cover more than one distinct sector in 
veterinary public health: a scoring system for emerging zoonosis developed in the Netherlands 
(32), a scoring model by a group of EU Chief Veterinary Officers (33), and the DISCONTOOLS 
scoring model (34). 
In 2006, the Netherlands National Institute for Public Health and the Environment developed the  
Dutch Emerging Zoonosis Information and Priority systems (EZIPs). EZIPs provided a scoring 
model for zoonosis that ranked seven categories of interest (32): 
1. Probability of introduction into the Netherlands   
2. Transmission in animal reservoirs   
3. Economic damage, animal reservoirs   
4. Animal-human transmission   
5. Human-human transmission   
6. Morbidity   
7. Mortality 
Not all the seven categories had the same importance and a coefficient of weight was applied, 
indeed, animal-human transmission (coefficient 0.63) and mortality (0.64) were identified as the 
two most important categories. Through EZIPs model 86 zoonosis were assessed (data available 
at http://ezips.rivm.nl/pathogens/). 
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In 2008, a working group of EU Chief Veterinary Officers proposed a complex scoring model 
for infectious diseases. This model assessed implication of animal diseases on public health, 
farming economy, society, and trade. The working group identified six areas of interest and four 
to ten criteria for each area, specifically (33): 
1. Epidemiology (10 criteria). 
2. Control measures (8 criteria). 
3. Impact on public health (4 criteria). 
4. Impact on economy (4 criteria). 
5. Impact on society (4 criteria). 
6. Impact on trade (4 criteria). 
Criteria may be scored from 1 (best case) to 5 (worst) and each criterion has a coefficient so that 
the total of weighted criteria in each areas is 10 (areas may score between 10 and 50) (33). 
DISCONTOOLS is an on-going project founded by EU members states that involves industry, 
researchers and EU public health officers. The aims of this project are: 
1. To develop a disease prioritization system in order to prioritize researches in diagnostics, 
vaccines, and pharmaceuticals. Thus, to improve surveillance and control of animal 
diseases. 
2. To identify gaps among the diseases assessed and to identify where further researches are 
needed. 
3. To increase efficiency of new technologies for animal health.  
In 2011, DISCONTOOLS project (DP) developed a scoring system (see Table 2) for 
prioritisation and gaps identification in infectious animal diseases (34, 35). This model covers six 
areas of interest such as disease knowledge, impact on animal welfare, impact on public health, 
impact on wider society, impact on trade, and control tools. Areas were subdivided by tree to ten 
criteria and each criteria could be ranked from 0 (best) to 4 (worst), with the exception of 
“control tools” where the scoring range were from +2 to -2. 
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Criteria  Scores Coef Total (score*coef) 
Disease knowledge  0 1 2 3 4   /100 
1. Speed of spread            2.5   
2. Score for number of species involved            2.5   
3. Persistence of infectious agent In the environment            2.5   
4. Risk of spread to susceptible populations            2.5   
5. Potential for silent spread            2.5   
6. Wildlife reservoir and potential spread            2.5   
7.Vector reservoir and potential spread            2.5   
8. Variability of the agent            2.5   
9. Understanding of fundamental immunology            2.5   
10. Host pathogen interaction            2.5   
Impact on animal health and welfare  0 1 2 3 4   /100 
1. Disease impact on production            8.33   
2. Duration of animal welfare impact            8.33   
3. Proportion of animals affected suffering pain/injury/distress as a result 
of the disease            8.33   
Impact on public health – human health  0 1 2 3 4   /100 
1. Impact of occurrence on human Health            4.16   
2. Likelihood of occurrence            4.16   
3. Impact of occurrence on Food Safety            4.16   
4. Transmissibility (spread from animals to humans)            4.16   
5. Spread in humans            4.16   
6. Bioterrorism potential            4.16   
Impact on wider society  0 1 2 3 4   /100 
1. Economic direct impact including cumulative cost (e.g. Enzootic vs. 
epizootic)            8.33   
2. Economic indirect impact (social, market)            8.33   
3. Agriterrorism potential            8.33   
Impact on trade  0 1 2 3 4   /100 
1. Impact on international Trade due to existing regulations            6.25   
2. Impact on EC Trade due to existing regulations            6.25   
3. Potential for regionalisation            6.25   
4. Impact on Security of Food supply            6.25   
Control Tools  2 1 0 -1 -2   /100 
1. Appropriate diagnostics            16.66   
2. Appropriate vaccines            16.66   
3. Appropriate pharmaceuticals            16.66   
Total score    
 
Table 2 – DISCONTOOLS scoring model for prioritisation. 
 
DISCONTOOLS working groups identified and assessed 52 animal diseases belonging to three 
categories (36): epizootic diseases (e.g. foot and mouth disease, bluetongue), food animal 
producing complexes (e.g. BVD, Staphylococcus aureus mastitis), and zoonotic diseases (e.g. 
bovine tuberculosis, cysticercosis).  
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An online database (http://www.discontools.eu/Diseases) contains all the information about 
scoring criteria, gap analysis, risk, and detailed characteristics of the 52 diseases analysed. The 
database is regularly updated on a 3-year cycle, however, novel information regarding specific 
diseases can be added anytime. In addition, new diseases may be included in future (37). 
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2 Aims of the study 
The main purpose of this study was to develop a trustworthy tool for characterize risks and 
identify priorities of animal diseases in very specific areas (health, economic, international 
trading, control programs, etc.) applicable at a regional-level. 
In order to identify priorities and risks of a given disease, a reliable model should consider the 
level of risk of that disease in all sectors of interest. Furthermore, it should facilitate the decision-
making process due to a rational, scientific and clear procedure that permits quick and efficient 
responses when known or emerging diseases are considered. Finally, it should highlight possible 
gaps of information (e.g. epidemiological data, costs of control plans in the region) concerning 
the diseases under assessment. 
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3 Materials and Methods 
To define risks and priorities within the diseases of interest in Lombardy region, a scorecard was 
developed (see Table 4) based on the model settled by DP (34, 35). 
The scoring model developed by DP evaluates a disease in the entire EU and it provides a 
scoring system regarding disease knowledge, impact on animal health and welfare, public health, 
wider society, trade and disease control tools. In contrast to DP model, the scorecard developed 
in this study is focused mainly on human health, food safety and economic impact of the 
diseases. Moreover, the target area, Lombardy region, is relatively narrow if compared to EU. 
 
3.1 Model development 
An expert panel (EP) was organized (academics and public health officers) in order to develop 
the scorecard and to establish a proper scoring system using DP model as core starting point. 
Furthermore, a guide (see Table 6 to Table 11) and a form were developed by EP to assign 
appropriate scores for each category (three examples of fulfilled forms are reported in the 
appendixes of this thesis). 
The form encompasses all the information needed to assign a proper scoring, and the guide 
explains how to translate these information in a score from one to five.  
The working group selected, among the available methods, the FCP (27) to develop the final 
version of the scorecard, the guide, and the form. Formalized Consensus Process is a five-step 
procedure which includes a systematic review of literature, an assessment of issues, initial 
proposals, a discussion and improvement of proposals and, finally, a validation of operational 
recommendations. In this specific case, the process involved the following steps: 
1. Systematic review of literature concerning models for risk characterization, prioritization 
and management of veterinary public health. In addition, EP identified the hazards to 
assess as contagious diseases and a preliminary list of these diseases was selected. 
2. Identification of main technical issues such as sources of information, EP meetings 
organisation, and lack of pre-existing models. Moreover, major areas of interest for 
veterinary public health at regional level were addressed, and the final list of diseases was 
established (see Table 3). 
3. Development of a first draft of scorecard, related guide and form: comments and 
suggestions were collected in joint meetings between EP and several veterinary officers 
of Lombardy region to refine the questions requested for assessment of a single criteria 
(e.g. “presence of the disease”).  
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4. Improvement of the draft: EP further discussed with veterinary officers of Lombardy 
region (VOL) and established a different “weight” for the areas of interest (see Table 5), 
and all categories within the areas were established (see Table 4). 
5. Test of pilot scorecards addressing three well-known diseases (bovine tuberculosis, 
bovine brucellosis, and enzootic bovine leucosis); the results were examined in a joint 
meeting between EP and VOL. This assembly produced the final structure of scorecard, 
guide, and form. The procedure for the assessment of the diseases (filling of the forms 
and scoring process) was also established. 
 
3.2 Expert panel 
The expert panel comprised veterinaries with either an academic or a public health management 
background. In detail, DIVET provided seven academics with at least 10 years of experience in 
research and control of infectious and/or parasitic diseases while VOL provided five veterinary 
officers with at least 10 years of experience in veterinary public health. Furthermore, DIVET and 
VOL selected one facilitator (the author of this thesis) and two collaborators with a degree in 
veterinary medicine and at least one year of experience in control of infectious or parasitic 
disease. These collaborators, alongside with the facilitator, expedited communication between 
VOL and DIVET outside the plenary meetings, managed the references (order and style), and 
provided basic assistance throughout all FCP steps and during the filling of diseases forms. 
Consensus was considered to be reached when at least 9 out 12 expert (75%) agreed on a given 
issue. 
 
3.3 Systematic review 
Systematic review started with a simple free-form question, exactly, are scoring model for risk 
characterization in veterinary public health available? 
In February 2011 an electronic research of Web Of Science (WOS) database was performed, 
general settings were “All years” and “All databases” while the keywords were the following: 
(veterinary) AND (“public health”) AND (“risk characterization” OR scoring OR prioritization). 
As control, the same search was carried within PubMed database. 
One hundred and one documents were founded in WOS (19 in PubMed); papers were considered 
admissible only if written in English and peer-reviewed (with the exception of documents by 
OIE, EFSA, and CDC), therefore, 16 papers out of 101 were excluded. 
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Quality assessment was conducted on the 85 articles left, a ranking system was adopted to 
identify pertinence of the papers, precisely: 
− Score = 0 (no pertinence): scientific documents completely out of topic, such as risk 
management in clinical veterinary medicine; epidemiology of antimicrobial resistances; 
new diagnostic techniques; risk factor for single aspects of a disease or for a specific 
problem of health/welfare of a single species. 
− Score = 1 (low pertinence): scoring systems regarding a specific aspect of a single given 
disease; general methodology and scientific opinion about risk characterization or disease 
prioritization. 
− Score = 2 (medium pertinence): scoring systems, applied in distinct sectors (e.g. human 
health, economics and animal welfare) for a single diseases or for more than one disease 
but in a single sector; specific scientific opinion concerning prioritization in zoonosis or 
food safety.  
− Score = 3 (high pertinence): single scoring models able to provide risk characterization 
in very distinct sectors and appropriate for diverse veterinary diseases of interest in public 
health. 
67 documents scored 0, 15 scored 1, 3 scored 2 (38-40) but no papers reached score 3; the results 
of the systematic review are collected in the Appendix D and the flowchart is illustrated in 
Figure 2. Since none of the scientific works founded were classifiable as high pertinent, EP 
adopted the DP model as starting point and the methodologies reviewed in (17) as source of 
additional information. 
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Paper admitted to further assessments 
85 documents 
Scoring system for quality assessment  
4 categories 
WOS database (“All years” and “All databases”) 
keywords: veterinary AND “public health” AND (“risk 
characterization” OR scoring OR prioritization). 
101 documents 
Preliminary exclusions  
(no peer-review, not English written) 
16 documents 
 
Score = 0 
(no pertinence) 
67 documents 
 
Score = 1 
(low pertinence) 
15 documents 
 
Score = 2 
(med. pertinence) 
3 documents 
 
Score = 3 
(high pertinence) 
0 documents 
 
Figure 2 − Flowchart of the systematic review 
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3.4 Disease selection 
The EP selected for assessment an initial group of 38 diseases of major interest in Lombardy 
region, classified by animal species affected, as summarized in Table 3. EP chose these disease 
for several reasons: they could be widespread, they may have a serious impact if introduced, or 
they are reportable diseases. Bacterial and viral infections represent the majority of the diseases 
selected, nonetheless, some protozoan, prion, and macroparasitic diseases were also included. 
 
Bovine Small Ruminant Swine 
Bovine brucellosis 
Bovine tuberculosis 
Bovine spongiform 
encephalopathy (BSE) 
Bovine viral diarrhoea (BVD) 
Enzootic bovine leucosis  
Infectious bovine rhinotracheitis 
(IBR) 
Listeriosis 
Mastitis (S. agalactiae) 
Mastitis (S. aureus) 
Paratuberculosis 
Salmonellosis (bovine) 
Blue tongue 
Brucellosis (small rum.) 
Contagious agalactia 
Query Fever 
Transmissible spongiform 
encephalopathy (small rum. TSE) 
Aujeszky’s disease 
Classic swine fever 
Porcine reproductive and 
respiratory syndrome (PRRS) 
Salmonellosis (swine) 
Swine erysipelas 
Swine vesicular disease 
Trichinosis (swine) 
   
Poultry Equine Others 
Avian campylobacter 
Avian influenza 
Fowl typhoid 
Newcastle disease 
Equine infectious anaemia 
Equine viral arteritis 
Trichinosis (equine) 
Campylobacteriosis (pets) 
Leishmaniasis 
Nosemosis 
Opisthorchiasis 
Rabies 
Toxoplasmosis 
Varroosis 
West Nile fever 
Table 3 – Diseases of interest in Lombardy, subdivided by species. 
 
Specifically, 11 bovine disease were selected. Three of them are reportable diseases included in 
the region official control plan (bovine tuberculosis, bovine brucellosis, enzootic bovine 
leucosis); three are considered to be a major risk for human health (bovine spongiform 
encephalopathy, listeriosis, salmonellosis) and the remaining four were chosen because of their 
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economic impact and/or as possible threat for public health (bovine viral diarrhoea, infectious 
bovine rhinotracheitis, paratuberculosis, contagious mastitis). 
All the five small ruminant diseases included present a relevant economic impact and/or pose a 
severe threat to animal health; furthermore, two of them are zoonosis (brucellosis, query fever). 
Seven swine diseases were included, three of them are a risk for human heath (salmonellosis, 
swine erysipelas, trichinosis) while the other four may pose a relevant threat for swine health 
and/or economics (Aujeszky’s disease, classic swine fever, swine vesicular disease, porcine 
reproductive and respiratory syndrome). 
Four major poultry diseases were selected for assessment because of their economic relevance 
(fowl typhoid, Newcastle disease) and/or their negative impact on public health (avian influenza, 
avian campylobacter).  
Three equine diseases were chosen, two of them are reportable diseases without zoonotic 
potential (equine infectious anaemia, equine viral arteritis) while the third (trichinosis) is also a 
severe threat for food safety.  
Finally, eight animal diseases were included within the category “other”; these are disease of 
interest for public health that cannot fit within only one of the previous categories 
(campylobacteriosis in pets, leishmaniasis, rabies, toxoplasmosis, West Nile fever, 
opisthorchiasis) or they represent a major problem for beekeeping (nosemosis, varrosis). 
 
3.5 Scoring process and data sources  
The scores of the selected diseases were proposed by two experts, one from DIVET and one 
from VOL, and then discussed by the EP during plenary meetings. These two expert, alongside 
with an assistant (the same of the FCP or the facilitator), filled a very specific form (see the 
appendix for three examples) that had to contain all the information needed for a proper scoring 
of each category within the scorecard. If, during this phase, some pivotal information were 
missing the scoring process was stopped until these information became available. Finally, the 
preliminary scores were considered approved when at least 9 out 12 expert (consensus set at 
75%) agreed on these ranks.  
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General and scientific information regarding the diseases under assessment came from peer-
reviewed scientific papers and reviews, only documents published on academic journal with an 
impact factor (IF) reported on Journal Citation Reports (JCR) were considered. Additional 
reliable scientific information were selected from other sources, precisely: 
− Scientific books: general scientific book on infectious diseases (e.g. Fenner's Veterinary 
Virology, IV Ed., edited by: N. J. Maclachlan and E. J. Dubovi, Academic Press, 2010, 
ISBN: 978-0-12-375158-4) or monographic publications about a specific disease (e.g. 
Paratuberculosis: Organism, Disease, Control, edited by M. A. Behr and D. M. Collins, 
CABI, 2010, ISBN: 978-1-84-593613-6). 
− World Organisation for Animal Health (OIE): Manual of Diagnostic Tests and Vaccines 
for Terrestrial Animals (available at http://www.oie.int/international-standard-
setting/terrestrial-manual/access-online/) and technical disease cards (available at 
http://www.oie.int/animal-health-in-the-world/technical-disease-cards/). 
− Center for Food Security and Public Health (CFSPH) of Iowa State University: Diseases 
Technical Factsheet (available at http://www.cfsph.iastate.edu/DiseaseInfo/). 
− Other institutes and organisations: publications by World Health Organization (WHO), 
Centers for Disease Control and Prevention (CDC), European Food Safety Authority 
(EFSA), European Centre for Disease Prevention and Control (ECDC), European 
Medicines Agency (EMA), Food and Agriculture Organization of the United Nations 
(FAO). 
Various organisations reports and an international database were selected as source of 
epidemiological data such as: 
− VOL official reports. 
− Experimental Zooprophylactic Institutes reports. 
− Italian national epidemiological bulletins. 
− EFSA reports. 
− ECDC reports. 
− CDC reports. 
− WHO reports. 
− World Animal Health Information Database (WAHID). 
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4 Results  
Two main results were produced during this study: the scorecard model itself and the subsequent 
ranking of 23 of 38 diseases identified by the EP as diseases of particular interest at Regional-
level. 
 
4.1 Scorecard final model 
The scorecard model, developed during the FCP, represents the first result of the study. This 
final model was also included and published in the VPP of Lombardy region.  
The final model of the scorecard (Table 4) covers six areas of interest:  
1. Disease relevance. 
2. Socio-economic impact. 
3. Impact on public health (human).  
4. Impact on trade.  
5. Impact on animal welfare. 
6. Control tools.  
Each area is composed of different categories. The number of categories within each area vary 
from a minimum of four (socio-economic impact, impact on trade, control tools) to a maximum 
of 11 (relevance of the disease).  
The scoring system of the model and the categories of the various areas will be further described 
in the following sections. 
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SCORECARD 
Disease Name SCORE = 551 
Criteria Score Coef Tot 
1 Relevance Of The Disease 1 2 3 4 5 1.43 41.4 
1.1 Presence of the disease 1         
2.86 
  
1.2 Frequency of the disease   2         
1.3 Number of species involved     3     4.29   
1.4 Speed of spread       4   5.71   
1.5 Vectors as reservoir and potential source of the disease         5 7.14   
1.6 Risk of spread to susceptible species       4   5.71   
1.7 Wildlife as reservoir and potential source of the disease     3     4.29   
1.8 Potential for silent spread   2       2.86   
1.9 Variability of the agent 1         1.43   
1.10 Knowledge of host-pathogen interaction   2       2.86   
1.11 Knowledge of immunology     3     4.29   
2 Socio-Economic Impact 1 2 3 4 5 10.00 100 
2.1 Impact on production within the region 1         10.00   
2.2 Economic impact of the control plan   2       20.00   
2.3 Potential economic direct impact     3     30.00   
2.4 Potential economic indirect impact       4   40.00   
3 Impact On Public Health 1 2 3 4 5 8.57 189 
3.1 Relevance in laws (locals to international) 1         8.57   
3.2 Zoonotic potential   2       17.14   
3.3 Likelihood of occurrence     3     25.71   
3.4 Spread in humans       4   34.29   
3.5 Impact on human health         5 42.86   
3.6 Impact on food safety       4   34.29   
3.7 Bioterrorism potential     3     25.71   
4 Impact On Trade 1 2 3 4 5 10 100 
4.1 Impact on regional trade due to current laws 1         10   
4.2 Impact on national / EU trade due to current laws   2       20   
4.3 Impact on international trade due to current laws     3     30   
4.4 Potential for zoning       4   40   
5 Impact On Animal Welfare 1 2 3 4 5 2.86 71 
5.1 Potential impact on animal welfare (duration)         5 
57.14 
  
5.2 Potential frequency of severe distress       4     
5.3 Severity / reversibility of the disease     3     8.57   
5.4 Impact on animal freedom   2       5.71   
6 Control Tools 1 2 3 4 5 5 50 
6.1 Proper tools for diagnosis 1         5   
6.2 Proper tools for prevention (within the region/area)   2       10   
6.3 Proper tools for control (within the region/area)     3     15   
6.4 Proper tools for therapy       4   20   
 
Table 4 – Scorecard model (scores are illustrative). 
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4.1.1 Scoring system 
All categories may be scored from 1 (best case) to 5 (worst) and, in order to ensure an identical 
score within the same area, a correction factor is applied after the scoring (“coeff.” in Table 4). 
Moreover, each area presents a coefficient of weight, from 1 to 3, based on the relevance of the 
area itself (Table 5); these coefficients of weight were established by the EP during the FCP. 
The final score of the model is the sum of the scores of all areas and may reach and its 
theoretical maximum is 1,000. Furthermore, every area presents a criticality level (Table 5) 
expressed in percent and calculated as the ratio of its score and the highest score achievable and 
(maximum theoretical level 100%). 
Microsoft® Excel 2010 (Microsoft Corporation, Redmond WA) was used to perform all the 
calculation. 
Area of interest Coefficient Max. Weight Crit. % 
1. Relevance Of The Disease 1 100 Up to 100% 
2. Socio-Economic Impact 2 200 Up to 100% 
3. Impact On Public Health 3 300 Up to 100% 
4. Impact On Trade 2 200 Up to 100% 
5. Impact On Animal Welfare 1 100 Up to 100% 
6. Control Tools 1 100 Up to 100% 
 
Table 5 – Summary of areas of interest, weight and criticality levels. Criticality levels represents the percentage of maximum 
theoretical score that the disease can reaches in the related area of interest, based on its score in that area. 
 
4.1.2 Relevance of the disease 
“Relevance of the disease” has a coefficient of weight equal to 1 and 11 categories, this area 
interest focus on epidemiological and scientific data.  
The most relevant categories are “presence of the disease” and “frequency of the disease”. 
“Presence of the disease” analyses where the infection is reported (in the region, in Italy or in 
EU) and “frequency of the disease” assesses disease epidemiological pattern (from sporadically 
to endemic). The scores of these two categories are multiplied between themselves and provide 
over one-third of the final score of their area of interest. 
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The remaining categories examine scientific knowledge available regarding a given disease, 
specifically: 
− Number of species involved 
− Speed of spread 
− Vectors as reservoir and potential source of the disease 
− Risk of spread to susceptible species 
− Wildlife as reservoir and potential source of the disease 
− Potential for silent spread 
− Variability of the agent 
− Knowledge of host-pathogen interaction 
− Knowledge of immunology 
Table 6 illustrates the scoring criteria of the 11 categories related to “relevance of the disease”. 
 
4.1.3 Socio-economic impact 
“Socio-economic impact” has a coefficient of 2 and 4 categories. Two categories, named “impact 
on production within the region” and “economic impact of the control plan”, consider the actual 
impact of the diseases within the region. “Impact on production within the region” is represented 
by the current losses (production and quality) and “economic impact of the control plan” by the 
cost of the control plan (if present). The other two categories, “potential economic direct impact” 
and “potential economic indirect impact”, assess the potential socio-economic impact of a 
disease (direct and indirect) in the worst-case scenario. “potential economic direct impact” 
analyses the cost of control (therapies, vaccination, culling, etc.) and the risks on production 
losses. “Potential economic indirect impact” examines potential market loss, impact of the 
disease on public health budget (human cases only), reduction of tourism, and threats to 
biodiversity. Table 7 reports the scoring criteria for the estimation of socio-economic impact. 
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Area of interest and 
Categories Score 
1 Relevance Of 
The Disease 
1 2 3 4 5 
1.1 Presence of the 
disease 
None Present in EU / 
neighbour 
nations 
Present in the 
nation / 
neighbour 
regions 
Present in the 
Region 
Endemic 
1.2 Frequency of the 
disease 
None Low 
Occasional 
reports. 
Never studied / 
Unknown 
High 
Reservoirs 
present and 
stable (livestock, 
pet, wildlife or 
vectors). 
Very high 
1.3 Number of species 
involved 
Never studied, 
likely limited.  
One species. Limited 
2 species. 
High 
3 species. 
Very high 
4 species or 
more. 
1.4 Speed of spread None 
Not 
transmissible. 
Very slow 
Low level of 
spread within the 
herd, unlikely 
between herds. 
Slow 
Slow spread 
between herds 
only with animal 
movements. 
Fast 
Spread between 
herds with or 
without animal 
movements. 
Very Fast 
Fast spread 
between herds 
without animal 
movements. 
1.5 Vectors as 
reservoir and 
potential source of 
the disease 
None 
No biological / 
mechanical 
vectors  
Low 
Presence of the 
vectors 
unknown, very 
unlikely within 
the country. 
Medium 
Vectors present 
within the 
country but not 
considered 
capable of 
surviving and 
transmitting the 
disease. 
High 
Vectors present 
within the 
country and able 
of transmitting 
the disease but 
not considered 
capable of 
surviving. 
Very high 
Vectors are a 
stable presence 
within the 
country and 
capable of 
transmitting the 
disease. 
1.6 Risk of spread to 
susceptible 
species 
None 
Not contagious. 
Low 
Spread only due 
to direct contact. 
Unknown High 
Spread also due 
to indirect 
contact. 
Very High 
Airborne. 
1.7 Wildlife as 
reservoir and 
potential source of 
the disease 
None 
No wild animal 
reservoir / 
potential source 
of the disease. 
Low 
Low prevalence 
in isolated wild 
animals. 
Medium 
Wild animals 
reservoir but no 
direct contact 
with livestock, 
pets or humans. 
High 
Wild animals 
reservoir, 
occasional 
contact with 
livestock, pets or 
humans. 
Very High 
Wild animals 
reservoir in close 
contact with 
livestock, pets or 
humans 
1.8 Potential for silent 
spread 
None 
 
Low 
Signs of 
infection easily 
recognised and 
likely to occur in 
animal under 
control. 
Medium 
Signs of 
infection easily 
recognised but 
depends on level 
/ plans of 
surveillance. 
High 
Specific 
diagnosis may be 
difficult in one or 
more species. 
Very High 
Disease/infection 
not likely to be 
detected for 
certain time. 
1.9 Variability of the 
agent 
None 
One type only, 
stable host/vector 
Low 
Few types 
without 
mutation, stable 
host and vectors 
(if any) 
Medium 
Few types 
without mutation 
but low host-
specificity, stable 
vectors (if any). 
High 
Numerous types 
or mutating, low 
host-specificity 
or vector -
specificity. 
Very High 
Numerous types 
and mutating, 
low host- or 
vector -
specificity. 
1.10 Knowledge of 
host-pathogen 
interaction 
Complete 
knowledge of 
host-pathogen 
interaction. 
Almost complete 
knowledge of 
host-pathogen 
interaction. 
Partial 
knowledge of 
host-pathogen 
interaction. 
Almost no 
knowledge of 
host-pathogen 
interaction. 
No knowledge of 
host-pathogen 
interaction. 
1.11 Knowledge of 
immunology 
Complete 
knowledge of 
immunology 
(both humoral 
and cellular). 
Complete 
knowledge of 
humoral 
immunity Partial 
knowledge of 
cellular 
immunity. 
 
Partial 
knowledge of 
immunology 
(both humoral 
and cellular). 
Partial 
knowledge of 
humoral 
immunity only. 
No knowledge of 
immunology. 
Table 6 – Relevance of the disease: categories and scoring criteria. 
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Area of interest and 
Categories Score 
2 Socio-Economic 
Impact 
1 2 3 4 5 
2.1 Impact on 
production within 
the region 
None 
Production is not 
touched. 
Very low 
Some production 
losses but no 
serious impact on 
the income (< 
5%). 
Low 
Production losses 
< 20%. 
Qualitative drop 
of products is 
possible. 
Medium 
Production losses 
> 20%. 
Qualitative drop 
of products. 
High 
Production losses 
> 50% and 
Menace to 
survival of 
livestock 
industry. 
2.2 Potential 
economic direct 
impact 
None 
No restrictions or 
mandatory 
control measures.  
Very low 
Restrictions on 
animal transfers 
or some 
production losses 
(< 5%). 
Low 
Restrictions on 
production; 
mandatory 
vaccination (or 
similar control 
measures) or 
production losses 
< 20%. 
Medium 
Restrictions on 
production; 
mandatory test 
and cull or  
production losses 
> 20%. 
High 
Restrictions on 
production; 
mandatory 
stamping out or 
menace to 
survival of 
livestock 
industry. 
2.3 Potential 
economic indirect 
impact 
None 
No drop / 
restrictions on 
products 
distribution, 
tourism or 
biodiversity. 
Very low 
Minor 
consequences on 
products 
distribution, 
tourism or 
biodiversity. 
Low 
Herd products 
redirected to 
lower value 
markets. Possible 
damages on 
tourism or 
biodiversity  
Medium 
Market price 
reduced 
temporarily by 
less than 30% . 
Relevant impact 
on public health 
budget. 
Damages on 
tourism or 
biodiversity.  
High 
Market price 
reduced 
temporarily by 
more than 30%  
over a month or a 
country-wide 
ban. Important 
impact on public 
health budget, on 
tourism or 
biodiversity. 
2.4 Economic impact 
of the control plan 
None 
No control plan 
available. 
Very low 
Voluntary control 
plan or 
surveillance 
Low 
Mandatory 
control plan due 
to the free-status 
(only 
surveillance 
needed). 
Medium 
Mandatory 
control with rare 
outbreaks 
(surveillance + 
outbreak 
closure). 
High 
Mandatory 
control with 
numerous 
outbreaks 
(disease common 
in the region).  
 
Table 7 – Socio-economic impact: categories and scoring criteria. 
 
4.1.4 Impact on public health 
“Impact on public health” has a coefficient of 3, 7 categories, and it represents the most 
important area of the scorecard. This area considers the relevance in the regional / national / 
international laws (“relevance in laws”). Moreover, “Impact on public health” includes “zoonotic 
potential” analyses the human-animal interface and the routes of spread between animals and 
humans. “Likelihood of occurrence” considers the incidence of a disease in the region. “Spread 
in humans” assesses the likelihood of transmission between humans. “Impact on human health” 
analyses the effects of a disease on human health such as severity of symptoms, permanent 
health damage, and fatality rate.  
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Area of interest and 
Categories Score 
3 Impact On 
Public Health 
1 2 3 4 5 
3.1 Relevance in laws 
(locals to 
international) 
None Regional National EU Area International 
3.2 Zoonotic potential None  
Transmission 
between animals 
and human is not 
possible. 
Very low 
Transmission 
between animals 
and human is not 
known or no 
information 
available. 
Low 
Transmission is 
possible due to 
direct contact 
with live animals. 
Medium 
Transmission is 
possible due to 
direct / indirect 
contact with live 
animals, vectors 
or food. 
High 
Very low species 
barrier, possible 
airborne 
transmission or 
through the 
environment. 
3.3 Likelihood of 
occurrence 
None  
Proven 
impossibility of 
transmission to 
humans through 
live animals, 
animal products, 
vectors or food. 
Very low 
Probability lower 
than 1/1.000.000. 
Low 
Probability lower 
than 1/100.000. 
Medium 
Probability lower 
than 1/10.000. 
High 
Probability 
higher than 
1/1.000. 
3.4 Spread in humans None  
Transmission 
between humans 
is not possible. 
Very low 
Transmission 
between humans 
is not known but 
very unlikely. 
Low 
Transmission 
between humans 
is uncommon. 
Medium 
Transmission 
between humans 
requires 
prolonged or high 
level challenge. 
High 
Transmission 
between humans 
occurs 
frequently. 
3.5 Impact on human 
health 
None  
Humans are not 
considered 
susceptible to 
infection. 
Very low 
Symptoms are 
mild, transitory 
without lasting 
effects. 
Low 
Symptoms may 
require time off 
work (up to 
1week) and/or 
medical 
intervention. 
Medium 
Symptoms often 
provoke medical 
intervention, 
possible long 
term health 
effects (>1 
month). Severe 
pain and 
discomfort. 
Fatalities are 
uncommon. 
High 
High case fatality 
(>5%) and/or 
permanent health 
effects. 
3.6 Impact on food 
safety 
None  
Transmission via 
food is not 
possible. 
Very low 
Very low level of 
contamination of 
food, unlikely to 
cause problems. 
Low 
Low level of 
contamination 
that can cause 
disease/infection 
only if agents are 
ingested in large 
quantities. 
Medium 
Medium 
probability of 
spread via food 
but large 
numbers of 
organisms 
needed to cause 
problems. 
Precaution  
measures 
required. 
High 
High probability 
of spread via 
food with small 
infective dose 
and strict 
precautions 
required. 
3.7 Bioterrorism 
potential 
None  
Agent 
unavailable / 
impossible to 
handle or 
harmless to 
humans. 
Very low 
Agent available 
but difficult to 
handle or low 
potential to harm 
humans. 
Low 
Agent available 
and easy to 
handle by 
professionals and 
labs but with low 
potential to harm 
humans. 
Medium 
Agent available 
and easy to 
handle by 
professionals and 
labs and with 
high potential to 
harm humans. 
High 
Agent available 
and easy to 
handle by single 
individuals and 
with high 
potential to harm 
humans. 
Table 8 – Impact on public health: categories and scoring criteria. 
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“Impact on food safety” reflects both the likely level of contamination in food and the infectious 
dose. Finally, “bioterrorism potential” evaluates the availability of the agent and its potential, if 
used as a biological weapon, to cause substantial harm. Table 8 reports the scoring criteria 
implemented for assess impact on public health of a given disease. 
 
4.1.5 Impact on trade 
“Impact on trade” has a coefficient of 2 and 4 categories. Three categories consider the impact of 
a disease in regional / EU / international trade according to the current legislation. Namely, 
“impact on regional trade due to current laws”, “impact on national / EU trade due to current 
laws”, and “impact on international trade due to current laws”. Their scores are based on the 
restriction on trades if an outbreak occurs or if the disease is endemic; the risk of losing an “area-
free” status (when present) and the difficulty to regain this status. 
The fourth category, “potential for zoning”, analyses the possibility to create restricted areas in 
order to control an outbreak (from the single positive farm to the entire Country). Table 9 
illustrates the categories and the scoring criteria regarding the impact on trade of a disease. 
Area of interest and 
Categories Score 
4 Impact On Trade 1 2 3 4 5 
4.1 Impact on 
regional trade due 
to current laws 
None 
No restrictions or 
only at animal-
level. 
Low 
Restrictions only 
at heard- / farm-
level. 
Medium 
Restrictions at 
zone-level and/or 
list of  banned 
commodities . 
High 
Restrictions at 
zone-level and 
without list of 
banned 
commodities. 
Very high 
Restrictions / ban 
at regional-level. 
4.2 Impact on national 
/ EU trade due to 
current laws 
None 
No restrictions or 
only at animal-
level. 
Low 
Restrictions only 
at heard- / farm-
level 
Medium 
Restrictions at 
zone-level or list 
of banned 
products. 
High 
Restrictions at 
zone-level with 
or without list of 
banned 
commodities. 
Very high 
Restrictions / ban 
at national-level. 
4.3 Impact on 
international trade 
due to current 
laws 
None 
No restrictions or 
only at animal-
level. 
Low 
Restrictions only 
at heard- / farm-
level or further 
restrictions only 
in small number 
of countries due 
to particularly 
strict laws. 
Medium 
Restrictions at 
zone-level or list 
of banned 
products. No loss 
of  “free-status”. 
Strong 
restrictions in 
large number of 
countries due to 
national laws. 
High 
Restrictions at 
zone-level and 
loss of  “free-
status”  but short 
recovery period 
of the status. 
Very high  
Restrictions / ban 
at national-level, 
loss of  “free-
status”  with long 
recovery period. 
4.4 Potential for 
zoning 
Very High 
Zoning possible 
at heard / farm 
level 
High 
Zoning possible 
within 10 kms (6 
miles) 
Medium 
Zoning possible 
but more than 10 
kms needed. 
Low 
Zoning possible 
due to using 
wider 
administrative 
boundaries 
None 
Only 
compartments. 
Table 9 – Impact On Trade: categories and scoring criteria. 
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4.1.6 Impact on animal welfare 
“Impact on animal welfare” has a coefficient of 1 and 4 categories. Specifically, “Potential 
impact on animal welfare (duration)” evaluates the duration of negative effects on animal 
welfare induced by a diseases. “Potential frequency of severe distress” assesses the percentage of 
animal with severe distress during an outbreak. “Severity / reversibility of the disease” analyses 
the consequences of a disease on animal health, such as severity of symptoms and permanent 
health damage; therapy availability and success are also assessed. 
The fourth category, “impact on animal freedom”, considers the potential restriction on four out 
of the “Five Freedom”. Indeed, “Freedom from Fear and Distress” was not included within the 
scoring criteria because it was not considered relevant to the purposes of the scorecards.  
“Impact on animal welfare (duration)” and “potential frequency of severe distress” are 
multiplied between themselves and provide over two-third of the final score of this area. 
Table 10 reports the scoring criteria of the 4 categories related to “impact on animal welfare”. 
 
Area of interest and 
Categories Score 
5 Impact On 
Animal Welfare 
1 2 3 4 5 
5.1 Potential impact 
on animal welfare 
(duration) 
None 
No impact. 
  
Very low 
Less than 48 
hours. 
Low 
48 hours - 14 
days. 
Medium 
15 days - 24 
months. 
Permanent 
More than 24 
months. 
5.2 Potential 
frequency of 
severe distress 
None 
No animal 
infected. 
Very low 
<5% in severe 
distress. 
Low 
6-20%  in severe 
distress. 
Medium  
21-50%  in 
severe distress. 
High 
>50 %  in severe 
distress. 
5.3 Severity / 
reversibility of the 
disease 
Asymptomatic Mild clinical 
signs, self-
limiting or 
minimum therapy 
needed. 
Moderate clinical 
signs and therapy 
needed. 
Severe clinical 
signs with 
possible therapy 
failure and 
permanent health 
effects. 
Severe clinical 
signs, no therapy 
available and 
permanent health 
effects. 
5.4    Impact on animal 
freedom 
No limitations on 
“Animal 
Freedoms“ 
(Freedom from 
Fear and Distress 
NOT included). 
Limitations on 1 
Freedom 
(Freedom from 
Fear and Distress 
NOT included). 
Limitations on 2 
Freedoms 
(Freedom from 
Fear and Distress 
NOT included). 
Limitations on 3 
Freedoms 
(Freedom from 
Fear and Distress 
NOT included). 
Limitations on 4 
Freedoms 
(Freedom from 
Fear and Distress 
NOT included). 
Table 10 – Impact On Animal Welfare: categories and scoring criteria. 
 
4.1.7 Control tools 
“Control tools” has a coefficient of 1 and 4 categories.  The category “Proper tools for 
diagnosis” encompasses validated kits availability within the nation; laws that rule the 
surveillance; techniques described by international organisation (OIE, WHO, UE) and DIVA test 
availability in order to emit an overall judgement on these tools. Moreover, an overall judgement 
on both available tools for control and tools adopted within the region is required. 
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 “Proper tools for prevention” and “Proper tools for control” categories examine obstacles, 
incentives, available approaches, and vaccination strategies (i.e. laws, availability and efficacy) 
with the purpose of assess the status of surveillance, prevention and control in the region.  
Finally, “Proper tools for therapy” considers the presence of appropriate protocols for therapy (if 
permitted) and related legislation. 
Table 11 illustrates the scoring criteria adopted for risk characterisation in the area of interest 
“control tools”. 
Area of interest and 
Categories Score 
6 Control Tools 1 2 3 4 5 
6.1 Proper tools for 
diagnosis 
Very high High Medium   Low  None 
6.2 Proper tools for 
prevention (within 
the region/area) 
Very high High Medium   Low  None 
6.3 Proper tools for 
control (within the 
region/area) 
Very high High Medium   Low  None 
6.4 Proper tools for 
therapy 
Very high / 
Forbidden 
High Medium   Low  None 
Table 11 – Control Tools: categories and scoring criteria. 
 
4.2 Scores of the diseases 
The scorecard model, once approved from the Regional health authorities, was used for assessing 
risk priorities on an initial number of diseases affecting different food-producing species and, in 
few cases, pet animals. 
To date 23 diseases out of the 38 selected were evaluated and Table 17 reports total scores and 
criticality levels of these diseases. In addition, the detailed scores of each disease are reported in 
the next sub-chapters (see Table 13 to Table 16). 
The 15 diseases present in Table 3 but not yet scored are under scrutiny, as an on-going process. 
Indeed, data available on these 15 remaining diseases were considered insufficient or unreliable, 
and thus, they are still under examination.  
Table 12 reports an extract of the scorecard form about the area of interest “controls tools”. 
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6 CONTROL TOOLS 
6.1 Proper tools for diagnosis 
6.1.1 Validated kits availability within the 
nation  
To be filled 
6.1.2 Laws that rule the surveillance To be filled 
6.1.3 Techniques described by international 
organisation (OIE, WHO, UE, etc.) 
To be filled 
6.1.4 DIVA test possibility / obligation of use  To be filled 
6.1.5 Overall judgement on tools for control To be filled 
6.2 Proper tools for prevention (within the region/area) 
6.2.1 Obstacles / incentives to prevention To be filled 
6.2.2 Available prevention strategies and their 
efficacy 
To be filled 
6.2.3 Commercial vaccines availability in EU / 
Worldwide 
To be filled 
6.2.4 Marker vaccines availability in EU / 
Worldwide 
To be filled 
6.2.5 Vaccination efficacy To be filled 
6.2.6 Laws that rule vaccination To be filled 
6.3 Proper tools for control (within the region/area) 
6.3.1 Obstacles / Incentives to control To be filled 
6.3.2 Available control strategies and their 
efficacy 
To be filled 
6.3.3 Laws that rule control strategy To be filled 
6.4 Proper tools for therapy 
6.4.1 Therapeutic protocol in use (cure and 
prophylaxis) 
To be filled 
6.4.2 Laws that rule therapies To be filled 
6.4.3 Residual risks / suspension time To be filled 
Table 12 – Control Tools: scorecard form. 
 
4.2.1 Categories and final scores: bovine diseases 
Final scores, among the 10 bovine diseases evaluated, vary from 327 to 547. Specifically:  
− Mastitis (S. aureus) (547)  
− Salmonellosis (537)  
− Paratuberculosis (528)  
− Bovine brucellosis (524)  
− Mastitis (S. agalactiae) (509)  
− Bovine tuberculosis (507)  
− Listeriosis (484)  
− BVD (458)  
− IBR (441)  
− Enzootic bovine leucosis (327) 
Table 13 reports the detailed scoring for each category of these diseases and their final score. 
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Categories 
Relevance Of The Disease Score 
Presence of the disease 4 5 5 3 4 3 5 5 4 3 
Frequency of the disease 4 3 4 1 4 1 3 5 4 1 
Number of species involved 2 5 5 5 2 5 5 5 2 2 
Speed of spread 3 4 3 2 3 3 3 3 3 2 
Vectors as reservoir and potential source of the disease 2 3 1 1 1 1 1 2 1 2 
Risk of spread to susceptible species 4 5 3 4 4 4 2 5 5 2 
Wildlife as reservoir and potential source of the disease 2 4 3 4 2 5 4 2 2 2 
Potential for silent spread 5 4 5 4 5 4 4 5 3 4 
Variability of the agent 5 5 3 4 4 4 4 5 3 3 
Knowledge of host-pathogen interaction 3 2 3 2 3 2 3 2 2 2 
Knowledge of immunology 3 2 3 2 3 1 2 2 1 2 
Socio-Economic Impact Score 
Impact on production within the region 4 2 3 1 4 2 2 4 3 1 
Economic impact of the control plan 2 1 2 3 2 4 1 1 2 3 
Potential economic direct impact 4 2 3 4 3 4 2 4 4 4 
Potential economic indirect impact 2 3 2 4 2 3 2 2 2 1 
Impact On Public Health Score 
Relevance in laws (locals to international) 4 5 1 5 3 5 5 1 1 1 
Zoonotic potential 4 5 2 4 4 4 4 1 1 1 
Likelihood of occurrence 3 3 2 2 2 2 2 1 1 1 
Spread in humans 2 3 1 4 3 3 3 1 1 1 
Impact on human health 3 3 4 4 3 3 3 1 1 1 
Impact on food safety 4 4 2 4 2 3 4 1 1 1 
Bioterrorism potential 2 3 1 3 2 2 2 1 1 1 
Impact On Trade Score 
Impact on regional trade due to current laws 2 2 2 2 2 2 2 1 3 2 
Impact on national / EU trade due to current laws 2 2 2 2 2 2 1 3 3 2 
Impact on international trade due to current laws 1 2 2 2 1 2 1 2 3 2 
Potential for zoning 1 1 5 1 1 1 1 5 1 1 
Impact On Animal Welfare Score 
Potential impact on animal welfare (duration) 4 3 5 4 4 4 3 4 3 4 
Potential frequency of severe distress 3 2 2 2 3 2 2 2 4 2 
Severity / reversibility of the disease 4 3 5 2 4 4 4 3 3 5 
Impact on animal freedom 3 3 3 3 3 3 4 4 3 2 
Control Tools Score 
Proper tools for diagnosis 2 2 4 1 2 1 2 2 4 2 
Proper tools for prevention (within the region/area) 4 4 4 2 4 2 4 4 4 2 
Proper tools for control (within the region/area) 3 4 4 2 3 2 4 4 4 1 
Proper tools for therapy 3 2 5 1 3 1 3 1 1 1 
Final weighted score 547 537 528 524 509 507 484 458 441 327 
 
Table 13 – Bovine diseases: partial and final scores. 
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4.2.2 Categories and final scores: small ruminants diseases 
Final scores, among the four small ruminant diseases evaluated, vary from 401 to 551. 
Specifically:  
− Query fever (551) 
− Small ruminants brucellosis (524) 
− Blue tongue (499) 
− Contagious agalactia (401) 
Table 14 reports the detailed scoring for each category of these diseases and their final score. 
  
36 
 
 
Q
ue
ry
 fe
ve
r 
Br
uc
el
lo
si
s (
sm
. r
um
.) 
Bl
ue
 to
ng
ue
 
C
on
ta
gi
ou
s a
ga
la
ct
ia
 
Categories 
Relevance Of The Disease Score 
Presence of the disease 4 3 3 4 
Frequency of the disease 3 1 1 3 
Number of species involved 5 5 4 3 
Speed of spread 4 2 5 3 
Vectors as reservoir and potential source of the disease 5 1 5 1 
Risk of spread to susceptible species 5 4 5 4 
Wildlife as reservoir and potential source of the disease 4 4 4 2 
Potential for silent spread 4 4 3 4 
Variability of the agent 5 4 4 4 
Knowledge of host-pathogen interaction 4 2 2 3 
Knowledge of immunology 3 2 2 2 
Socio-Economic Impact Score 
Impact on production within the region 2 1 1 2 
Economic impact of the control plan 1 3 2 2 
Potential economic direct impact 4 4 5 4 
Potential economic indirect impact 3 4 4 1 
Impact On Public Health Score 
Relevance in laws (locals to international) 4 5 1 1 
Zoonotic potential 5 4 1 1 
Likelihood of occurrence 3 2 1 1 
Spread in humans 3 4 1 1 
Impact on human health 3 4 1 1 
Impact on food safety 2 4 1 1 
Bioterrorism potential 3 3 1 1 
Impact On Trade Score 
Impact on regional trade due to current laws 2 2 3 2 
Impact on national / EU trade due to current laws 2 2 3 2 
Impact on international trade due to current laws 2 2 3 2 
Potential for zoning 2 1 4 1 
Impact On Animal Welfare Score 
Potential impact on animal welfare (duration) 2 4 3 4 
Potential frequency of severe distress 2 2 5 4 
Severity / reversibility of the disease 2 2 5 4 
Impact on animal freedom 3 3 5 5 
Control Tools Score 
Proper tools for diagnosis 3 1 2 2 
Proper tools for prevention (within the region/area) 5 2 4 3 
Proper tools for control (within the region/area) 4 2 3 3 
Proper tools for therapy 3 1 4 3 
Final weighted score 551 524 499 401 
 
Table 14 – Small ruminants diseases: partial and final scores. 
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4.2.3 Categories and final scores: swine diseases 
Among the six swine diseases evaluated the scores vary from 359 to 615, precisely: 
− Salmonellosis (615) 
− Classic Swine Fever (424) 
− Aujeszky’s disease (414) 
− Swine Erysipelas (406) 
− Swine vesicular disease (403) 
− PRRS (359) 
Table 15 reports the detailed scoring for each category of these diseases and their final score.  
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Categories 
Relevance Of The Disease Score 
Presence of the disease 4 1 5 4 3 4 
Frequency of the disease 4 1 4 2 1 4 
Number of species involved 5 2 5 5 2 2 
Speed of spread 4 3 3 3 4 4 
Vectors as reservoir and potential source of the disease 3 1 3 1 1 3 
Risk of spread to susceptible species 5 5 3 4 5 5 
Wildlife as reservoir and potential source of the disease 4 2 3 1 2 2 
Potential for silent spread 4 2 4 3 3 3 
Variability of the agent 5 2 2 4 3 4 
Knowledge of host-pathogen interaction 2 2 1 2 2 2 
Knowledge of immunology 2 2 1 2 2 1 
Socio-Economic Impact Score 
Impact on production within the region 3 1 2 3 1 4 
Economic impact of the control plan 4 3 4 1 3 1 
Potential economic direct impact 4 5 3 3 5 4 
Potential economic indirect impact 3 2 1 1 2 1 
Impact On Public Health Score 
Relevance in laws (locals to international) 5 1 1 3 1 1 
Zoonotic potential 4 1 1 3 1 1 
Likelihood of occurrence 4 1 1 2 1 1 
Spread in humans 3 1 1 1 1 1 
Impact on human health 3 1 1 4 1 1 
Impact on food safety 4 1 1 1 1 1 
Bioterrorism potential 3 1 1 1 1 1 
Impact On Trade Score 
Impact on regional trade due to current laws 2 4 1 2 4 1 
Impact on national / EU trade due to current laws 2 4 5 2 4 1 
Impact on international trade due to current laws 2 4 5 2 4 1 
Potential for zoning 1 2 1 1 2 1 
Impact On Animal Welfare Score 
Potential impact on animal welfare (duration) 3 3 3 4 3 4 
Potential frequency of severe distress 3 5 2 2 2 3 
Severity / reversibility of the disease 4 5 3 4 4 3 
Impact on animal freedom 3 2 3 2 2 2 
Control Tools Score 
Proper tools for diagnosis 2 1 2 2 1 3 
Proper tools for prevention (within the region/area) 4 1 2 2 1 3 
Proper tools for control (within the region/area) 4 1 2 2 1 2 
Proper tools for therapy 3 1 1 2 1 2 
Final weighted score 615 424 414 406 403 359 
 
Table 15 – Swine: partial and final scores. 
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4.2.4 Categories and final scores: other diseases 
Three diseases of the “other” group were scored as follows: 
− Toxoplasmosis (575) 
− West Nile fever (498) 
− Opisthorchiasis (444) 
Table 16 reports the detailed scoring for each category of these diseases and their final score.  
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Categories 
Relevance Of The Disease Score 
Presence of the disease 4 3 4 
Frequency of the disease 3 2 3 
Number of species involved 5 5 4 
Speed of spread 4 3 2 
Vectors as reservoir and potential source of the disease 2 5 5 
Risk of spread to susceptible species 5 4 3 
Wildlife as reservoir and potential source of the disease 4 5 3 
Potential for silent spread 5 4 5 
Variability of the agent 2 3 2 
Knowledge of host-pathogen interaction 1 3 2 
Knowledge of immunology 1 3 3 
Socio-Economic Impact Score 
Impact on production within the region 2 3 3 
Economic impact of the control plan 1 2 2 
Potential economic direct impact 1 1 2 
Potential economic indirect impact 2 1 2 
Impact On Public Health Score 
Relevance in laws (locals to international) 5 5 4 
Zoonotic potential 5 5 4 
Likelihood of occurrence 5 3 3 
Spread in humans 4 3 1 
Impact on human health 3 4 3 
Impact on food safety 5 1 5 
Bioterrorism potential 1 1 1 
Impact On Trade Score 
Impact on regional trade due to current laws 1 1 1 
Impact on national / EU trade due to current laws 1 1 1 
Impact on international trade due to current laws 1 1 1 
Potential for zoning 5 4 3 
Impact On Animal Welfare Score 
Potential impact on animal welfare (duration) 3 3 1 
Potential frequency of severe distress 3 3 1 
Severity / reversibility of the disease 5 5 1 
Impact on animal freedom 4 2 1 
Control Tools Score 
Proper tools for diagnosis 4 4 2 
Proper tools for prevention (within the region/area) 4 2 4 
Proper tools for control (within the region/area) 4 3 3 
Proper tools for therapy 5 4 1 
Final weighted score 575 498 444 
 
Table 16 – Other diseases: partial and final scores. 
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4.2.5 Scores summary and criticality levels 
All the final scores are summarised in Table 17. In addition, Table 17 reports criticality level for 
each area of interest of the assessed diseases. Indeed, every disease presents, at area-level, a 
criticality level calculated as the ratio of its score in that area and the highest score achievable 
(see Table 5). Criticality level are expressed in percent and are not influenced by the coefficient 
of weight of their area (see Table 5). 
The scorecards and the fulfilled forms of the 23 diseases in Table 17 are available (in Italian) on 
the Regional Veterinary Office website with access restricted to the Regional Veterinary Service 
officers. 
Three examples (bovine mastitis by S. aureus, bovine tuberculosis, bluetongue) of filled 
scorecards and their forms are reported in to the appendixes of this thesis. 
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Disease Final Score 
Relevance Of The 
Disease 
Socio-Economic 
Impact 
Impact On Public 
Health Impact On Trade 
Impact On 
Animal Welfare Control Tools 
Bovine 
       
Mastitis (S. aureus) 547 64% 60% 63% 30% 54% 60% 
Salmonellosis 537 70% 40% 74% 35% 34% 60% 
Paratuberculosis 528 70% 50% 37% 55% 51% 85% 
Bovine brucellosis 524 44% 60% 74% 35% 37% 30% 
Mastitis (S. agalactiae) 509 61% 55% 54% 30% 54% 60% 
Bovine tuberculosis 507 46% 65% 63% 35% 43% 30% 
Listeriosis 484 61% 35% 66% 25% 40% 65% 
BVD 458 80% 55% 20% 55% 43% 55% 
IBR 441 54% 55% 20% 50% 51% 65% 
Enzootic bov. leucosis 327 34% 45% 20% 35% 43% 30% 
Small ruminants 
       
Query fever 551 73% 50% 66% 40% 26% 75% 
Brucellosis (small rum.) 524 44% 60% 74% 35% 37% 30% 
Blue tongue 499 53% 60% 20% 65% 71% 65% 
Contagious agalactia 401 54% 45% 20% 35% 71% 55% 
Swine 
       
Salmonellosis 615 71% 70% 74% 35% 46% 65% 
Classic Swine Fever 424 31% 55% 20% 70% 63% 20% 
Aujeszky’s disease 414 64% 50% 20% 60% 34% 35% 
Swine Erysipelas 406 47% 40% 43% 35% 40% 40% 
Swine vesicular disease 403 39% 55% 20% 70% 34% 20% 
PRRS 359 60% 50% 20% 20% 49% 50% 
Others 
       
Toxoplasmosis 575 59% 30% 80% 40% 51% 85% 
West Nile fever 498 59% 35% 63% 35% 46% 65% 
Opisthorchiasis 444 56% 45% 60% 30% 9% 50% 
 
Table 17 – Final scores and criticality levels of the 23 assessed diseases. The colouration of criticality levels varies from green (lowest level) to red (highest level) and it is meant to facilitate the 
consultation of the table
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5 Discussion 
5.1 Methodological approach  
When we started our study, we had to select a methodological approach suitable for our aims. Our 
projected was part of a joint initiative, between VOL and DIVET, designed to improve efficiency, 
efficacy and quality of the regional veterinary services. Hence, the choice of the method was 
influenced by available resources (human and financial) and a fixed timeline (the final model had to 
be ready in about one year). 
We identified three approaches as potentially suitable for our objectives: consensus process, 
MCDA, and expert framework. An overview of the applications of these approaches in veterinary 
public health is reported in chapters 1.3 and 1.4.  
MCDA included a large number of techniques to develop models for the evaluation of different 
alternatives. These models could provide an evaluation system for the raking or the selection of the 
best alternatives and they were applicable for several problems, practices, interventions, and 
solutions. In addition, MCDA was applicable even when uncertainties were present such as future 
consequences of interventions (41), difficulties in problem identification (42), and limited 
availability of precise information (43). 
During the last few years, MCDA has seen an increasing popularity in healthcare and public health. 
Indeed, more than 50% of the papers about MCDA in healthcare were published since 2011, as 
reviewed in (44). However, these models focused only on human health and when we started our 
project there was only one published paper on the application of MCDA in veterinary public health. 
This study adopted MCDA to evaluate control strategies for classical swine fever within the EU 
(16). Recently, two interesting papers were published on the topic: one regarding the ranking of 
emerging threats to animal health in UK (45) and the other on the emergence of Lyme disease in 
Quebec (13).  
We decided to use an approach different from MCDA because we aimed to build a scoring model 
for the evaluation of very distinct areas of interest and each of these areas involved several 
uncertainties. Therefore, the development of a MCDA model in this background was not 
compatible with our resources. Precisely, we did not have enough human resources specialised in 
MCDA nor the time to develop this expertise because of our timeline. 
Over the last decade, different expert frameworks developed various scoring model for setting 
priority in veterinary public health (17). Among these model, the DP scoring system represented the 
most useful source for our study due to its assessment of animal diseases in very distinct sector. 
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However, we decided to not use the expert panel approach because it did not include a specific 
method to follow a priori and it had required the development of specific guidelines. Therefore, we 
considered our resources too limited for this approach. For example, DP involved more 360 experts 
from 35 countries, 52 expert groups, and an investment of over 1 million € (46, 47). 
Therefore, we identified the consensus process as the most suitable approach for our purposes. 
Indeed, these processes were based on consolidated guidelines and they were able to provide 
effective methods when scientific data is limited (12). The Delphi protocol represented the most 
applied consensus process. However, this protocol required anonymity in order to avoid dominant 
positions among the experts. Nonetheless, several member of our EP worked together or known 
each other, and thus, we considered the anonymity prerequisite difficult to satisfy. Hence, our final 
choice was FCP, a recently developed consensus process focused on healthcare and public health 
(27). After the setting of the final version of our model, the scorecards and their forms were 
proposed by two experts due to our strict deadlines. However, these forms and scores had to be 
approved by EP with, at least, the same degree of consensus (75%) adopted during the FCP. 
 
5.2 Development of the model and scoring criteria 
Tools for risk characterisation and prioritization should be based on scientific evidences. 
Nonetheless, these evidences are not always adequate, particularly in veterinary public health, and 
lack of specific data (or scientific papers) may undermine the development of a proper model. In 
conditions where the scientific evidence is scarce, consensus methods should be used to achieve 
agreement among experts (12). Indeed, we encountered two main obstacles during the development 
of our model. Namely, to find proper sources of information and to reach consensus within the 
working group, comparable difficulties were also reported in similar studies (48). 
Our first step to find suitable sources of information was a systematic review (see chapter 3.3 and 
Appendix D). However, the results of this review were underwhelming and none of the included 
papers reached, after the quality assessment, the maximum rank. 
Several models have been developed to prioritize disease on a broad scale (17), but none of them 
addressed scenarios involving specific areas and economic impact on a regional level, and thus, 
they provided an useful but limited source of information. In addition, different approaches and 
models for setting priorities in some fields of veterinary science, zoonosis, and food safety were 
proposed during the past years (12, 21, 32, 33, 48-50). Nevertheless, we did not find these models 
properly fit for the purposes of our project, with the exception of the recent DP model (35).  
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The DP model was an instrumental source of information because it facilitated identification and 
balance of both areas and categories in our scorecard. However, it should be emphasized that even 
if some diseases considered in DP and in our project are the same, the scorecards developed in in 
the two projects are different due to the different aims of the two projects. The scoring criteria and 
various categories are also different, and thus, a direct comparison between the scores of the 
diseases assessed by the two model is not feasible. 
We adopted the FCP for the development our model because it provided a solid method to decide 
which and how the above mentioned sources had to be used and to overcome the limitations caused 
by lacks of information. Nonetheless, consensus processes are time-consuming approaches and 
during the FCP we encountered the second main obstacle of this study. Namely, the reaching of 
consensus among the experts on some of the addressed topics. These sources of disagreement will 
be further discussed in the following paragraphs. 
The weight of the areas represented one of the main sources of conflict. Although the first draft and 
the final version of our scorecard included the same areas, the areas in the draft contributed equally 
to the total score of a disease (1/6 each). However, the focus of our model was primarily public 
health, and thus, some areas had to be more important than others. We identified “impact on public 
health” as the most important area. In addition, we recognised the vital importance of agro-food 
production in Lombardy, and so, the relevance of “socio-economic impact” and “impact on trade”. 
After setting these priorities, EP established a coefficient of three for “impact on public health” and 
a coefficient of two for both “socio-economic impact” and “impact on trade”. Nevertheless, is 
important to remark that the other areas (“disease relevance”, “impact on animal welfare”, “control 
tools”) should not be underestimated. Contrary to the weight of the areas, both the identification of 
the disease of interest and their grouping, based on species, were not a significant source of conflict. 
“Relevance of the disease” was one of the simplest areas of interest to develop and EP did not 
encounter relevant obstacles to reach the consensus. Certainly, it represented the area with the 
greatest number of scientific sources available, and we selected its 11 categories to encompass 
epidemiological and scientific data available on a given diseases (see Table 6). Furthermore, the DP 
model provided a remarkable starting point for this area of interest.  
The consensus process was slightly slowed-down only when the categories “presence of the 
disease” and “frequency of the disease” were discussed. Indeed, our goal was to develop a tool 
suitable at Regional-level and we identified these two categories as the most important of the entire 
area. In order to weight the two above mentioned categories we decided to multiply their scores 
between themselves, in this way, “presence of the disease” and “frequency of the disease” provided 
over one-third of the score of their area. 
46 
 
During the development of “socio-economic impact” area we pursued two objectives, namely, to 
analyse the actual economic impact of a disease in Lombardy and to estimate the potential impact of 
a disease in the worst-cases scenario (see Table 7). 
We recognised, as an actual impact of a disease, not only the losses of production (qualitative and 
quantitative) caused by this disease but also the cost of a mandatory control plan (if present in the 
Region). EP did not encountered major problems of consensus during the definition of the two 
categories that assess the actual impact of a disease in Lombardy. Specifically, “impact on 
production” and “economic impact of the control plan”. 
We identified two categories for the estimation of the potential impact of a disease: one focused on 
the direct impact and the other on the indirect impact. We developed the category “potential 
economic direct impact” to estimate the direct costs of the introduction of a new disease in the 
Region or the possible consequences of a present disease if left uncontrolled. This category was not 
a relevant source of conflict within the EP. On the other hand, defining the criteria to estimate 
indirect costs was more problematic.  
The first criterion identified for indirect impact was the potential price drop of food industry 
commodities. Indeed, in case of an outbreak of a zoonosis, fear and misinformation lead by mass 
media may cause relevant reduction of the market value. We also recognised the expenses for 
human treatments as potential source of indirect economic costs. For example, foodborne diseases 
from six agents (Salmonella, Campylobacter jejuni, Escherichia coli O157:H7, Listeria 
monocytogenes, Staphylococcus aureus, Clostridium perfringens) account for $2.9 − $6.7 billion in 
human health costs in the US each year (51). In addition, some experts proposed to comprise the 
impacts on tourism and on biodiversity because they both represented important resources for 
Lombardy region. In conclusion, EP reached consensus on the annexation of all the four above-
mentioned criteria. 
The evaluation of the category “Potential economic indirect impact” is heavily based on expert 
opinions (with the exception of human costs), and thus, particular carefulness should be employed 
during the scoring of this category. Furthermore, a new type of mass media will be encompassed in 
the future updates of the scorecards. Indeed, social networks has seen a massive increase of 
popularity during the last few years and these networks can now represent a concerning source of 
fear and misinformation, as recently happened with the ongoing outbreaks of Ebola virus disease. 
The development of the area “impact on public health” did not encounter great obstacles. The only 
two categories that will be briefly discussed are “relevance in laws (locals to international)” and 
“bioterrorism potential”. The other categories were based on epidemiology and they were already 
present in previous models (33, 34).  
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We included the category “relevance in laws (locals to international)” in order to contextualise the 
relevance of a zoonosis within the international laws, from a veterinary public health point of view. 
For example, bovine tuberculosis is included in both the OIE-Listed diseases (52) and the OIE 
Terrestrial Animal Health Code (53), while, swine erysipelas is contemplated only in at national-
level (Regolamento di Polizia Veterinaria, DPR 8 febbraio 1954, n. 320).  
The category “bioterrorism potential” in based on previous models (33, 34) and, in this case, the 
source of disagreement was if this category could be included or not within our scorecard. Finally, 
EP decided to include the category “bioterrorism potential” due to the large presence of potential 
sources of infectious agents (farm animals) and because the distribution of the population within 
Lombardy could facilitate the spread of an agent (large number of people in relatively narrow 
spaces). 
The area of interest “impact on trade” was settled to assess the restrictions due to an outbreak 
(present or potential) and it considered laws at various geographical levels such as regional, national 
/ EU, and worldwide. This area is based on the current laws and EP did not find noteworthy 
obstacles to consensus.  
We encompassed the extent of the restrictions (from single animal to regional-wide), the potential 
loss of free-status, states with particularly strict laws, and possible ban of commodities. In addition, 
we added a category, “potential for zoning”, that specifically addressed the size of the zone under 
restriction (see Table 9) because the possibilities of zoning directly influenced trade restrictions. 
We identified four categories for the area “impact on animal welfare” and we considered this area 
important for veterinary public health, although it did not represent one of the major focus of our 
model. The four categories of the area (see Table 10) had the same importance in the draft. 
Nonetheless, our main purpose was to highlight how a disease could pose a potential threat for 
welfare. We recognised the categories “potential impact on animal welfare (duration)” and 
“potential frequency of severe distress” as the two most appropriate for our purpose. Thus, EP 
agreed on multiplying the scores of these two categories between themselves so they could provide 
over two-third of the final score of the area. Finally, EP decided to not include the evaluation of the 
“Freedom from Fear and Distress” within the category “impact on animal freedom” because this 
Freedom was difficult to evaluate, and thus, it could complicate the model without providing 
significant benefits. In addition, several instruments are already available (49, 54-61) to further 
assess animal welfare. 
The last area, “control tools”, was developed to analyse the current status of prevention and control 
in the region and to assess the general availability of proper instruments for diagnosis and therapy.  
48 
 
We selected quite simple categories and scoring criteria (see Table 11) and we focused more on the 
related form (see Table 12). EP did not found relevant source of disagreement during the 
development of this part of the form. Nonetheless, the sections of the form on prevention and 
control in the region require to assess available strategies and their efficacy, to identify obstacles 
and incentives, and an overall judgement on tools for control. Hence, these sections are strongly 
influenced by expert opinions and particular attention should be posed during the scoring process. 
 
5.3 Scoring process and ranking of the diseases 
When scorecard forms were to be filled, lacks of data were manifest for some of the diseases under 
assessment. These deficiencies were particularly noticeable when frequency of the disease and 
categories encompassing costs were considered. Shortages of information were slowing down the 
process of filling forms, and lacks of pivotal data explain why not all the diseases in Table 3 have, 
to date, a completed scorecard. Nonetheless, the discover of these deficiencies also represents an 
important opportunity to identify and address gaps within surveillance or control plans. 
Final and partial scores of the 23 diseases analysed to date are based on 15 to 25 pages of forms 
with the collected information (see Appendix A, Appendix B, and Appendix C for three examples). 
Hence, the description and the discussion of scorecards for every single disease are not possible in 
this thesis. Nevertheless, some of the final scores (see Table 17) were unexpected and they deserve 
a brief discussion.  
During the ranking of bovine diseases, classical zoonosis, e.g. bovine tuberculosis, received lower 
scores when compared to other diseases such as S. aureus mastitis. Although these ranks may seem 
surprising, they confirm the usefulness of the model when applied in a specific area. Indeed, the 
relatively low score of bovine tuberculosis is due to the disease free-status of Lombardy, while S. 
aureus mastitis is highly prevalent and these infections, even if they are not considered to have a 
significant zoonotic potential, represent a possible source of exposure to methicillin-resistant 
Staphylococcus aureus (MRSA) strains (62, 63). S. aureus infections are currently a matter of 
concern for public health because of the ability of S. aureus to evade immune defences (64-67) and 
the increasing diffusion of MRSA in both human and domestic animal (62, 63, 68-71). 
Furthermore, S. aureus can produce enterotoxins that may lead to food poisoning even after thermal 
processes (72, 73). Therefore, the risk of human exposure is potentially high and the specific 
scorecard, undoubtedly, emphasize the potential risks for public health in Lombardy, in contrast to 
the common belief that these problems are confined only to dairy herds. 
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In case of small ruminants diseases, query fever reached a higher score than brucellosis (551 versus 
524, see Table 14 and Table 17) mainly because Lombardy is currently free of small ruminant 
brucellosis, while, query fever is present and proper plans for prevention or control are not available 
in the Region. In addition, the zoonotic potential of query fever is greatly enhanced by its primarily 
route of transmission, indeed, humans generally became infected through air-borne transmission 
(74). 
The rank of swine diseases did not highlight unattended results. Nonetheless, the negative economic 
impact of PRRS on pig industry can be dramatic (75). This disease should not be underestimated, 
even if is not a threat for human health or current trades, and its score should be revised frequently. 
The scoring process of the diseases within the group “other” is still at an early phase with only three 
out of eight diseases ranked.   
 
5.4 Final remarks: limits of the scoring model 
We believe that FCP was the most suitable method available for the aims study. Nonetheless, this 
process (and consensus processes in general) has its limitations. Therefore, in this chapter we will 
discuss the major limits of our model. 
The scorecard model is an instrument developed for professionals of our field, especially veterinary 
officers, and the scorecards and the related information can be misinterpreted by untrained people. 
In particular, the areas “impact on public health” and “socio-economic impact” may contain 
sensitive data (e.g. impact on food safety, bioterrorism potential, economic impact of the control 
plan) that may not be prone to cherry-picking or misapprehensions. “Impact on animal welfare” 
may also represent a source of misinterpretation. Although these outcomes are unlikely, we decided 
to publish the scorecards on the platform VetinWeb with access restricted to the Regional Veterinary 
Service officers. 
Another relevant limit, that may arise in future, is about the update of the scorecards. Indeed, our 
model is a dynamic tool that requires regulars updates, thus, the forms and the scores should be 
reviewed at least every three year. In addition, unscheduled updates should be made every time a 
major change in the disease background happens (e.g. gain/loss of official free-status, epidemics, 
breakthroughs in control strategies, etc.). However, the speed of the updates may be impaired by 
limited resources, both human and economic. 
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The last major limitation concerns the availability of data and information to fulfil the forms, and 
thus, to assign proper scores. As we already reported in chapter 5.3, some diseases are still under 
review because of data deficiencies. The most frequent sources of these uncertainties are 
epidemiological data or economic costs of diseases. Nonetheless, the discover of these gaps also 
represents a remarkable opportunity to address targeted researches. Hence, these studies may be 
aimed to identify significant weakness in risk management, surveillance and control plans. 
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6 Conclusions 
Prioritization tools are becoming increasingly important in developing health policies and strategies 
in preventive human and animal medicine and food safety.  These tools are available to assess and 
control important food safety aspects such as contamination during food processing, but there are 
very few focused on animal diseases and their impact on human health and food safety. Among the 
few models available, none of them is applicable in a definite geographical area comparable to 
Lombardy because they should fit not only with the disease epidemiological pattern but also with 
the specific socio-economic characteristics of the area. The tool we developed tries to fill these gaps 
encompassing not only diseases with zoonotic and food poisoning potentials but also animal 
infections with an alarming economic impact (real or potential).  
The scorecard model proposed represents the results of both veterinary researchers and veterinary 
officers’ expertise in veterinary public health and it is conceived to fit the Lombardy Region 
characteristics but, with minor modifications, it can be applied in similar geographical or political 
areas. 
Within this framework, areas of interest and related categories were built to be as much objective as 
possible and the scoring criterion was developed to be clear and easy to understand for professional 
involved in the process. However, it is important to emphasize that the objective of our scorecard 
model is not to provide a sterile score system about a given disease. Indeed, we developed this 
scoring model as a dynamic tool to help professionals in prioritization and decision-making in very 
distinct sector. Furthermore, our model is based on scientific evidences and a firm consensus 
protocol in order to support prioritisation in risk management and to avoid decisions based on 
cognitive bias or on the pressures of public opinion’s fears and misinformation driven by mass 
media. 
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Appendix A: Bovine Tuberculosis 
 
SCORECARD [last update 02-22-2012] 
BOVINE TUBERCULOSIS  SCORE = 507 Criteria Score Coef Total 
1 Relevance Of The Disease 1 2 3 4 5 1.43 45.7 
1.1 Presence of the disease     3     
4.29 
  
1.2 Frequency of the disease 1           
1.3 Number of species involved         5 7.14   
1.4 Speed of spread     3     4.29   
1.5 Vectors as reservoir and potential source of the disease 1         1.43   
1.6 Risk of spread to susceptible species       4   5.71   
1.7 Wildlife as reservoir and potential source of the disease         5 7.14   
1.8 Potential for silent spread       4   5.71   
1.9 Variability of the agent       4   5.71   
1.10 Knowledge of host-pathogen interaction   2       2.86   
1.11 Knowledge of immunology 1         1.43   
2 Socio-Economic Impact 1 2 3 4 5 10.00 130 
2.1 Impact on production within the region   2       20.00   
2.2 Economic impact of the control plan       4   40.00   
2.3 Potential economic direct impact       4   40.00   
2.4 Potential economic indirect impact     3     30.00   
3 Impact On Public Health 1 2 3 4 5 8.57 189 
3.1 Relevance in laws (locals to international)         5 42.86   
3.2 Zoonotic potential       4   34.29   
3.3 Likelihood of occurrence   2       17.14   
3.4 Spread in humans     3     25.71   
3.5 Impact on human health     3     25.71   
3.6 Impact on food safety     3     25.71   
3.7 Bioterrorism potential   2       17.14   
4 Impact On Trade 1 2 3 4 5 10 70 
4.1 Impact on regional trade due to current laws   2       20   
4.2 Impact on national / EU trade due to current laws   2       20   
4.3 Impact on international trade due to current laws   2       20   
4.4 Potential for zoning 1         10   
5 Impact On Animal Welfare 1 2 3 4 5 2.86 43 
5.1 Potential impact on animal welfare (duration)       4   
22.86 
  
5.2 Potential frequency of severe distress   2         
5.3 Severity / reversibility of the disease       4   11.43   
5.4 Impact on animal freedom     3     8.57   
6 Control Tools 1 2 3 4 5 5 30 
6.1 Proper tools for diagnosis 1         5   
6.2 Proper tools for prevention (within the region/area)   2       10   
6.3 Proper tools for control (within the region/area)   2       10   
6.4 Proper tools for therapy 1         5   
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 Summary Crit.   Coeff Weight 
1 Relevance Of The Disease 46%   1 100 
2 Socio-Economic Impact 65%   2 200 
3 Impact On Public Health 63%   3 300 
4 Impact On Trade 35%   2 200 
5 Impact On Animal Welfare 43%   1 100 
6 Control Tools 30%   1 100 
 
 
 SCORECARD FORM [last update 12-02-2012] 
Extra Disease 
E.1.1 Name of the disease 
Bovine tuberculosis 
E.1.2 Aetiological agent/s  
Mycobacterium bovis. Acid-fast (Ziehl–Neelsen stain), Gram positive, aerobic, coccus of the 
Mycobacterium tuberculosis complex. This complex includes M. tuberculosis, M. caprae (also 
common cause of bovine tuberculosis in Eastern Europe), M. africanum, M. canetti, M. microti, and 
M. pinnepedii. 
E.1.3 Brief description 
Diseases that can affect bovine and several other animal species (human included). Airborne 
transmission represents the most common cause of contagion in bovine, however, the infection may 
also occur via ingestion (foodborne) or, rarely, through wound contaminations.  
Clinical signs and anatomopathological lesions may vary greatly based on route of transmission, 
infectious dose, virulence of the strain, and resistance of the host. Symptomatology is variable but 
often includes weakness, weight loss, anorexia, and respiratory signs. 
Bovine tuberculosis is a zoonosis and, in humans, ingestion of infected raw milk represents the most 
frequent route of transmission. 
1 RELEVANCE OF THE DISEASE 
1.1 
1.2 Presence and frequency of the disease within the region / outside the region  
1.1.1 
1.2.1 
Presence and frequency of the disease within the region 
None. Lombardy is officially free (sporadic outbreaks). 
1.1.2 
1.2.2 
Presence and frequency of the disease within near region / country 
Italy –  Piedmont, Valle d’Aosta, Liguria, and all the region of centre-south of Italy (islands included). 
Europe – Several Countries such as Spain, Portugal, Greece, England, Ireland, Wales, Hungary, 
Romania, Latvia, and Lithuania. 
1.1.3 
1.2.3 
Frequency of epidemics (specify where) 
Not applicable. 
1.1.4 
1.2.4 
Animal Hosts / Vectors / Environment as source of disease 
Bovine represents both the natural host and the main reservoir of the diseases, however, some wild 
species may also act as reservoir for the infection. 
M. bovis is able to survive in the environment for long times, and thus, environment can be a possible 
source of disease. 
1.1.5 
1.2.5 
Seasonal cycles / outbreak influenced by climate anomalies 
Not applicable. 
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1.1.6 
1.2.6 
Factors that facilitate the presence of the agent (scarce hygiene, biosafety, management, etc.) 
Factors that facilitate the presence of the agent vary depending on the productive system (i.e. 
industrialized countries vs. developing countries).  
In developed countries these factors are: trade of infected bovines (inadequate surveillance), scarce 
control of bovine tuberculosis in wildlife, poor biosecurity, and management errors (overcrowding of 
susceptible hosts within areas at risk). 
1.1.7 
1.2.7 
Stability of the agent within the environment 
Medium to high. 
M. bovis is able to survive in the environment for years if the conditions are adequate (low 
temperature, high humidity, no direct exposure to the sun). In addition, M. bovis has a moderate 
resistance to drying (conflicting data about resistance to high temperatures).  
1.1.8 
1.2.8 
Likelihood of eradication  
Unlikely (possible in domestic species at farm-, region- or country-level). 
Eradication in wildlife may be impossible. Moreover, the epidemiological role of environment as 
source of disease need further clarifications. 
1.3 Number of species involved 
1.3.1 Number of species involved (specify which ones) 
High. 
Bovines, sheep, goats, cervids, equines, swine, buffaloes, bison, Canidae, felines, and rodents. 
1.4 Speed of spread 
1.4.1 Speed of spread within the farm 
Medium to low (depending on density and overcrowding). 
1.4.2 Speed of spread between farms 
Low (speed of spread may be slightly speeded-up in case of overcrowding and poor biosecurity). For 
example, in UK prevalence increased only from 1.3% (in 1996) to 3.5% (in 2003) despite the absence 
of restrictions and controls. 
1.4.3 Likelihood of spread without hosts movement outside the farm 
Unlikely. 
Airborne transmission requires close contact between animals. 
1.5 Vectors as reservoir and potential source of the disease 
1.5.1 Disease cycle influenced by vectors 
No. 
1.5.2 Presence of the vectors within the regional / national territory 
Not applicable. 
1.5.3 Presence of the vectors influenced by peculiar areas / climates 
Not applicable. 
1.5.4 Vectors likelihood of survival, reproduction, spread the disease, act as reservoir 
Not applicable. 
1.6 Risk of spread to susceptible species 
1.6.1 Likelihood of transmission 
Medium. 
Likelihood of transmission may vary based on density and overcrowding. 
1.6.2 Route of transmission 
M. bovis spreads mainly through expectoration, milk, or faeces. In addition, infection via urine, 
semen, or vaginal secretions is possible but not common. 
Transmission can be airborne, foodborne, or through infected wounds. The importance of these 
routes of transmission can vary depending on the species involved. Vertical transmission is also 
possible but very rare. 
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1.6.3 Peculiar condition that influence transmission 
Overcrowding and close contacts between contagious animals and sensible hosts (airborne 
transmission). Infected milk administered to calves (foodborne transmission). Frequent interactions 
between infected wildlife and sensitive domestic species. 
1.7 Wildlife as reservoir and potential source of the disease 
1.7.1 Species involved 
High. 
Cervids, Mustelidae, wild boars, rodents, Canidae, felines. In addition, several exotic species such as: 
buffaloes, bison, primates, American camelids, kudus, tapirs, elks, elephants, rhinoceroses, possums, 
etc..  
1.7.2 wildlife / livestock and pet / human interactions  
Wildlife can represent a source of bovine tuberculosis if contagious wild animals share areas with 
sensitive domestic species and humans. 
Deer can play an important role as reservoirs of the diseases in wildlife. Badgers seem to be an 
important source of infection in England and Ireland, they may transmit the diseases through several 
routes (bites and urines included) and, during the terminal phase of the infection, they seem to expel 
M. bovis in large doses. Wild boars are usually spillover hosts, however, in peculiar conditions (high 
density, favourable habitat and poor management) they may act as reservoir. 
1.7.3 Endangered species involved 
Some Spanish Authors has indicated the disease as possible threat for lynxes.   
1.8 Potential for silent spread 
1.8.1 Likelihood of recognition due to the clinical symptoms 
Low. 
Symptoms are usually not specific and manifest during the terminal phases of the disease.  
1.8.2 Spread by subclinical / asymptomatic hosts  
High. 
Several host can remain asymptomatic even for years (high risks in absence of proper surveillance). 
1.8.3 Incubation time 
On average months but sometimes years. 
1.9 Variability of the agent 
1.9.1 Species / Types 
One major species recognised (M. bovis), nonetheless, at least another species (M. caprae) can induce 
tuberculosis in bovine. 
1.9.2 Mutations 
Yes. Mutation can influence virulence and range of sensitive hosts. 
1.9.3 Number of hosts / vectors (host-specificity) 
High number of hosts, low host-specificity. 
1.10 Knowledge of host-pathogen interaction 
1.10.
1 
Status of knowledge of host-pathogen interaction 
Good. In addition, bovine tuberculosis provides and valuable experimental model for human 
tuberculosis. 
1.11 Knowledge of immunology 
1.11.
1 
Complete / partial / absent knowledge of humoral immunity 
Almost complete. In addition, immunity against bovine tuberculosis provides and valuable 
experimental model for human tuberculosis. 
1.11.
2 
Complete / partial / absent knowledge of cellular immunity 
Very good. In addition, immunity against bovine tuberculosis provides and valuable experimental 
model for human tuberculosis. 
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2 SOCIO-ECONOMIC IMPACT 
2.1 Impact on production within the region 
2.1.1 Production losses  
Lombardy is free of the disease, losses only in case of mandatory culling in according to current laws 
(surveillance ad control plan, DDUO97 01/12/2011) 
2.1.2 Quality losses 
Minor (possible quality losses in meat of infected animals). 
2.1.3 Menace to survival of livestock industry 
None (menace only at farm-level). 
2.2 Economic impact of the control plan 
2.2.1 Voluntary / mandatory control plan 
In Lombardy is active a mandatory control plan. 
2.2.2 Actual cost of the surveillance 
Low. In US some Authors estimated the cost of surveillance in 1 to 2 $ per animal every year. In 
Lombardy no scientific papers are available, however, according to regional specialists the yearly cost 
for diagnostic is around 0.90 € per animal (2010 costs, labour not included). 
2.2.3 Outbreak within the region (per year) 
Low to very low. 
− 11 outbreaks in 2005. 
− 14 outbreaks in 2006. 
− 11 outbreaks in 2007. 
− 2 outbreaks in 2009. 
− 4 outbreaks in 2010. 
− 1 outbreak in 2011. 
2.2.4 Adopted control measures and actual costs 
In case of outbreak mandatory tests and cull of infected animals (2003 US estimations): 
− $592.80 for the cull of an adult. 
− $112.00 for the cull of a calf. 
− $1390.00 for replacement of a milking cow ($1086.00 for a beef bovine). 
− $0.31 for every kg of milk lost (indirect losses for cull of milking cows and heifers). 
2.3 Potential economic direct impact 
2.3.1 Production and movement limited / banned 
Lombardy is officially free of bovine tuberculosis. 
Production and movement, at farm-level, are subject to limitations and bans in case of outbreak 
(suspension or revocation of free-status). Namely: 
− Milk of infected cows cannot be used for human consumption (destruction or for calves 
consumption within the farm after high-temperature processing). 
− Milk of uninfected cows can be stocked, according the regulations, after proper high-
temperature processing. 
− Trade of raw milk for direct human consumption is banned (DDUO97 01/12/2011). 
− Trade of semen and embryos not in compliance with Italian laws is banned (Law 126/63; 
D.P.R. 505/82, 226/92, 241/92). 
2.3.2 Potential economic cost 
The economic costs are mostly due to control measures. 
  
62 
 
2.3.3 Control strategies available (vaccination and therapy / Test-and-cull / Stamping out) 
Three control approach may be used, depending on epidemiological status (DDUO97 01/12/2011): 
− Test and cull. 
− Modified stamping out (cull of infected and suspected animals). 
− Stamping out. 
2.3.4 Costs of intervention (surveillance and control) 
Surveillance – In US the cost of surveillance is estimated in 1 to 2 $ per animal every year (2003). In 
Lombardy no published data are available, however, according to regional specialists the yearly cost 
for diagnostic is around 0.90 € per animal (2010 costs, labour not included). 
Control – In case of outbreak (2003 US estimations): 
− $592.80 for the cull of an adult. 
− $112.00 for the cull of a calf. 
− $1390.00 for replacement of a milking cow ($1086.00 for a beef bovine). 
− $0.31 for every kg of milk lost (indirect losses for cull of milking cows and heifers). 
In addition, administrative costs (salary for professionals involved in the control plan), refunds for 
culled animals, and costs related to equipment used during interventions.  
2.4 Potential economic indirect impact 
2.4.1 Consequences on the distribution of the products 
Lombardy is officially free of bovine tuberculosis, no indirect consequences on the distribution of the 
products (only direct in case of outbreak). 
2.4.2 Market value losses 
None reported at the moment. 
2.4.3 Nation-wide ban of distribution 
None (only direct consequences and merely at farm-level). 
2.4.4 Cost of treatments and control of the disease in humans 
Neglectable at regional-level. 
Costs for single patient may be very high. However, in Italy, during the last years, only 5 to 10 
confirmed human cases per year. Specifically, costs of treatments and control of the disease in 
humans due to: 
− Prolonged pharmacological treatments. 
− Hospitalisation for days to months. 
− Labour of medical personnel. 
− Possible (but uncommon) long-lasting disability as consequence of the disease. 
2.4.5 Tourism losses and menace to biodiversity 
Low but not numerically estimated. Potential losses in tourism and hunting activities in case of high 
prevalence the disease in the wildlife. 
2.4.6 Restriction on the entire productive system 
None at the moment, very unlikely in future. 
3 IMPACT ON PUBLIC HEALTH 
3.1 Relevance in laws (locals to international) 
3.1.1 Relevance in laws (region / nation / EU / worldwide)  
International (OIE Terrestrial Animal Health Code – Chapter 11.6). 
3.2 Zoonotic potential 
3.2.1 Possibility of transmission between animals and humans (yes / no / unclear) 
Yes. 
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3.2.2 Likelihood of transmission between animals and humans 
Very low in countries where pasteurisation is widespread and eradication plans are mandatory. In EU, 
during 2008, only 115 confirmed cases (0.02 cases / 100,000 inhabitants). 
Confirmed cases in Italy during the last years (>0.01 cases / 100,000 inhabitants): 
− 27 cases from 2004 to 2007. 
− 1 case in 2008.  
− 5 cases in 2009. 
3.2.3 Route of transmission from animals to humans (direct, indirect; vector, food, environment, airborne) 
The most important route of transmission, from animals to humans, is through ingestion of raw 
infected milk. Airborne transmission and infection through cutaneous wounds are also possible but 
uncommon. 
3.2.4 Species barrier 
Very low to none. 
3.2.5 Virulence factors 
Several virulence factors (molecules of the wall cell or secreted peptides) induce various degrees of 
virulence in different M. bovis strain, among the most important: 
− Trehalose 6,6'-dimycolate (TDM or Cord Factor), glycolipid of the wall cell, seems to impede 
leukocyte extravasation and to be toxic for leukocytes and hepatocytes. 
− Lipoarabinomannan (LAM), glycolipid of the wall cell, provides protection against reactive 
oxygen species (ROS) and seems to inhibit phagocytosis. 
− The antigen 85 complex (secretion proteins) seems to impair cellular immunity. 
− Proteins encoded by mce operons, seem to be pivotal for invasion of the epitheliums, and 
entry and survival inside macrophages. 
− Stress proteins (superoxide dismutase, alkyl hydroperoxidase) provide protection against ROS. 
3.2.6 Likelihood of underestimate human cases 
Likely. 
Infected humans may remain asymptomatic for years. 
3.3 Likelihood of occurrence 
3.3.1 Probability of occurrence 
Very low (in Italy >0.01 cases / 100,000 inhabitants per year). 
3.4 Spread in humans 
3.4.1 Likelihood of transmission between humans 
Very rare between immune-competent humans. Possible between immunocompromised patients. 
3.4.2 Route of transmission between humans (direct, indirect) 
Airborne transmission between humans in close contact.  
3.5 Impact on human health 
3.5.1 Severity of the disease 
Variable (from asymptomatic to life-threating). In addition, the firsts symptoms may occur years after 
the contagion. 
Clinical signs vary based on localization of the lesions (e.g.: lungs, liver, kidney) and severity of the 
disease. 
3.5.2 Symptoms duration and time off work length 
The disease is typically chronic.  
Clinical infections require a prompt treatment (the disease can be fatal) and a long time off work, 
hospitalization may also be prolonged. 
3.5.3 Permanent damages 
Possible but uncommon.  
Permanent damages depend on severity of the diseases and promptness of the treatment. 
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3.5.4 Mortality 
Sporadic. Mortality may occur if the disease is left untreated or in immunocompromised patients. 
3.6 Impact on food safety 
3.6.1 Likelihood of infection / intoxication due to infected / contaminated food 
Variable (very unlikely in Lombardy).  
Foodborne transmission may occur due to ingestion of infected raw milk or other infected foods. 
3.6.2 Infectious / toxic dose 
Infectious dose is not exactly clear but it seems high (estimated in millions of UFC). 
3.6.3 Mandatory precautions 
Lombardy is free of bovine tuberculosis.  
Mandatory precautions are required in case of suspension or loss of the free-status such as (DR 97 
01/12/2011):  
− Milk of infected cows cannot be used for human consumption (destruction or for calves 
consumption within the farm after high-temperature processing). 
− Milk of uninfected cows can be stocked, according the regulations, after proper high-
temperature processing. 
− Trade of raw milk for direct human consumption is banned. 
3.7 Bioterrorism potential 
3.7.1 Potential to cause substantial harm in humans 
Bioterroristic potential of M. bovis is neglectable (not in included in category A or B of CDC list of 
potential bioterrorism agents). 
3.7.2 Agent availability 
Not applicable. 
3.7.3 Facility of use and conservation (Labs / trained professionals / sole person) 
Not applicable. 
4 IMPACT ON TRADE 
4.1 Impact on regional trade due to current laws 
4.1.1 Ban / Limitations on trade (positive animal only, herd, limited area, region-wide) 
Lombardy is free of bovine tuberculosis (no limitations on trade between free farms). 
Ban and limitations are possible at farm-level in case of suspension or loss of the free-status, in 
compliance with the current laws (DDUO97 12/01/11). 
4.1.2 List of banned products 
Lombardy is free of bovine tuberculosis (no banned products).  
In case of suspension or loss of the free-status, bans are on:  
− Sell of raw milk for direct human (DDUO97 12/01/11) 
− Trade of semen and embryos not in compliance with the Italian laws (Law 126/63; D.P.R. 
505/82, 226/92, 241/92) and EU laws (88/407/EEC; 2003/43/EC). 
4.1.3 Free-status loss 
Possible suspension or loss of the free-status; in case of outbreak the zone of control is usually at 
farm-level (DDUO97 12/01/2011). 
4.1.4 Difficulty and time needed to regain free-status 
Suspension – medium to low difficulty: suspensions can occur due to the presence of suspected 
animals within the farm or the violations of laws on animal movements. In order to regain the free 
stratus intradermoreaction test (IDT) must be negative for all animals older than six weeks within the 
farm. These animals must be tested at least 42 days after the cull of the suspected animals or the 
violations (DDUO97 12/01/2011). 
Loss – medium difficulty: losses of free-status occur in case of outbreak. free-status can be regained 
four months after the cull of all infected animals if, in the farm, all the animals older than six weeks 
are negative to IDT (DDUO97 12/01/2011). 
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4.2 Impact on national / EU trade due to current laws 
4.2.1 Ban / Limitations on trade (positive animal only, herd, limited area, nation-wide) 
Lombardy is free of bovine tuberculosis (no limitations on trade between free farms). 
Ban and limitations are possible at farm-level in case of suspension or loss of the free-status, in 
compliance with the current laws (64/432/EEC). 
4.2.2 List of banned products 
Lombardy is free of bovine tuberculosis (no banned products).  
Possible bans on trade if semen or embryos are not in compliance with the Italian laws (Law 126/63; 
D.P.R. 505/82, 226/92, 241/92) and EU laws (88/407/EEC; 2003/43/EC). 
4.2.3 Free-status loss 
Italy is not officially free of bovine tuberculosis. 
4.3 Impact on international trade due to current laws 
4.3.1 Ban / Limitations on trade (positive animal only, herd, limited area, nation-wide or EU-wide) 
Lombardy is free of bovine tuberculosis (no limitations on trade between free farms among the 180 
OIE member states). 
Ban and limitations are possible at farm-level in case of suspension or loss of the free-status, in 
compliance with the current laws (OIE Terrestrial Animal Health Code – Chapter 11.6). 
4.3.2 List of banned products 
Lombardy is free of bovine tuberculosis (no banned products).  
Products subject to possible banned are: milk and meat (in case of suspension or loss of the free-
status), semen or embryos (if not in compliance with the current laws). 
4.3.3 Free-status loss 
Italy is not officially free of bovine tuberculosis. 
4.3.5 Countries with particularly strict laws (about the disease) 
Not applicable (current laws are already strict). 
4.4 Potential for zoning 
4.4.1 Zone of control size 
Zoning is conceivable at farm-level (DDUO97 12/01/2011). 
5 IMPACT ON ANIMAL WELFARE 
5.1 Potential impact on animal welfare (duration) 
5.1.1 Presence and duration of animal welfare damages 
Chronic infections may impair animal welfare, mortality is rare. 
Severity of the diseases may vary based on virulence of the strain, susceptibility of host 
species/breed, host immune status and immune response. 
5.2 Potential frequency of severe distress 
5.2.1 Percentage of animal with severe distress 
Variable (from 0 to 10% of infected cattle may develop severe distress). 
5.3 Severity / reversibility of the disease 
5.3.1 Severity of the disease and reversibility of the damages 
Severity of the disease can vary, severe infections with irreversible damages are possible. 
Bovine tuberculosis is typically a chronic diseases, however, infections with a relatively rapid 
progression may occur.  
Clinical symptoms can vary depending on the localization and the dimension of the lesions induced by 
M. bovis. The most common signs are fever (wavelike), progressive impairment, weakness, and lack of 
appetite. In addition, severe infections usually induce strong respiratory symptoms and severe 
distress. 
5.3.2 Available therapies and their effectiveness 
Not applicable. Treatments are forbidden by laws and infected animals must be culled. 
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5.4 Impact on animal freedom 
5.4.1 Potential restriction on the “Five Freedom” (freedom from fear and distress NOT included) 
In countries that adopt efficient surveillance control plans infected animals are usually identified 
before the manifestation of any symptoms. Clinical infections may impede: 
− Freedom from pain, injury or disease. 
− Freedom from hunger and thirst (in case of extremely severe infections). 
6 CONTROL TOOLS 
6.1 Proper tools for diagnosis 
6.1.1 Validated kits availability within the nation  
Not applicable (diagnosis regulated by current laws). 
6.1.2 Laws that rule the surveillance 
Common surveillance on all farms (periodical), all animal movements, and in case of outbreak 
(DDUO97 12/01/2011): 
− IDT to all bovine and buffaloes older than six weeks in compliance with the control plan. 
− Accurate Post-mortem visit in the slaughterhouse and sampling of all the suspicious lesion 
(the sample will be tested by the zooprophylactic institute competent for the zone). 
Specific surveillance in case of outbreak (DDUO97 12/01/2011): 
− Agent isolation. 
− Interferon-gamma test in possible in some cases (see “allegato D” of DDUO97 12/01/2011). 
6.1.3 Techniques described by international organisation (OIE, WHO, UE, etc.) 
OIE MANUAL OF DIAGNOSTIC TESTS AND VACCINES FOR TERRESTRIAL ANIMALS (Chap. 2.4.7): 
 
a) Identification of  BTV 
− Microscopic examination. 
− Culture (OIE gold standard). 
− Nucleic acid recognition methods (PCR , spoligotyping, restriction endonuclease analysis 
(REA), restriction fragment length polymorphism (RFLP), mycobacterial interspersed 
repetitive units (MIRU)-variable number tandem repeat (VNTR) typing) 
b) Tuberculin test (delayed hypersensitivity test prescribed test for international trade) 
c) Blood-based laboratory tests 
− Gamma-interferon assay (alternative test for international trade, stimulation with avian and 
bovine PPD-tuberculin, ESAT 6, or CFP-10) 
− Lymphocyte proliferation assay (available only in few labs and very expensive, for research 
purposes only). 
− ELISA techniques. 
6.1.4 DIVA test possibility / obligation of use  
None available.  
Gamma-interferon assay based on stimulation with ESAT 6, or CFP-10 may discriminate between 
infected and vaccinated animals. 
6.1.5 Overall judgement on tools for control 
The tools for control adopted in Lombardy seem to be adequate to eradicate the disease at farm-
level, and thus, maintaining the free-status. 
6.2 Proper tools for prevention (within the region/area) 
6.2.1 Obstacles / incentives to prevention 
Incentives – Mandatory plan of surveillance, control, and eradication. 
Obstacles – Control of disease in the wildlife, illicit introduction of animal from areas at risk, illegal use 
of antibiotics. 
  
67 
 
6.2.2 Available prevention strategies and their efficacy 
The most important available prevention strategies are: 
− Strict controls on animal movements. 
− High standards of biosecurity. 
− Avoid direct or indirect contacts between sensitive domestic hosts and reservoirs wild species 
− Proper epidemiological surveillance  
6.2.3 Commercial vaccines availability in EU / Worldwide 
None, no commercial vaccine available within EU. 
6.2.4 Marker vaccines availability in EU / Worldwide 
None. 
6.2.5 Vaccination efficacy 
Counter-productive when a proper plan for surveillance, control, and eradication is active. Moreover, 
in countries where vaccination is permitted the efficacy of immunisation interventions is inconsistent. 
6.2.6 Laws that rule vaccination 
Vaccination is forbidden (by the ministerial decree number 592 of December 15 1995). 
6.3 Proper tools for control (within the region/area) 
6.3.1 Obstacles / Incentives to control 
Incentives – Mandatory plan of surveillance, control, and eradication with a usually favourable cost-
benefit. For example, in US the neat benefit of the plan for 2003 was 159 millions of dollars. In Ireland 
cost-benefit analysis has (CBA) estimated high benefits (benefit surpass cost for an 85%). 
Obstacles – Control of disease in the wildlife, illicit introduction of animal from areas where the 
disease is present, illegal use of antibiotics, risks of unfavourable cost-benefit if the control measures 
are not optimised (as reported by English and Spanish Authors). 
6.3.2 Available control strategies and their efficacy 
Various strategies available such as: 
− Test and segregation (low efficacy). 
− Test and cull (low efficacy when used alone). 
− Strict plan for surveillance, control and eradication (good efficacy to gain the free-status). 
− Surveillance and control of the wildlife (costly). 
6.3.3 Laws that rule control strategy 
The plan of surveillance, control and eradication is mandatory for every farm, within Lombardy, that 
breed bovine or buffaloes (DDUO97 12/01/2011). 
6.4 Proper tools for therapy 
6.4.1 Therapeutic protocol in use (cure and prophylaxis) 
Treatment is forbidden and detrimental for both the control plan and the public health (risks of 
antibiotic resistance). Moreover, therapeutic protocol exits but they are expensive and provide 
inconsistent results. 
6.4.2 Laws that rule therapies 
Therapies are strictly forbidden, in addition, if suspicious lesions are founded during post-mortem 
visits the bulk milk of the farm where the animal was from must be tested for isoniazid residual 
(DDUO97 12/01/2011). 
6.4.3 Residual risks / suspension time 
Non applicable. 
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Appendix B: Bovine Mastitis (S. aureus) 
 
SCORECARD [Last update 08-30-2013] 
BOVINE MASTITIS (S. aureus) SCORE = 547 
Criteria Score Coef Tot 
1 Relevance Of The Disease 1 2 3 4 5 1.43 64.3 
1.1 Presence of the disease    4  22.86   
1.2 Frequency of the disease    4    
1.3 Number of species involved  2    
2.86   
1.4 Speed of spread   3   
4.29   
1.5 Vectors as reservoir and potential source of the disease  2    
2.86   
1.6 Risk of spread to susceptible species    4  
5.71   
1.7 Wildlife as reservoir and potential source of the disease  2    
2.86   
1.8 Potential for silent spread     5 
7.14   
1.9 Variability of the agent     5 
7.14   
1.10 Knowledge of host-pathogen interaction   3   
4.29   
1.11 Knowledge of immunology   3   
4.29   
2 Socio-Economic Impact 1 2 3 4 5 10.00 120 
2.1 Impact on production within the region    4  40.00   
2.2 Economic impact of the control plan  2    20.00   
2.3 Potential economic direct impact    4  40.00   
2.4 Potential economic indirect impact  2    20.00   
3 Impact On Public Health 1 2 3 4 5 8.57 189 
3.1 Relevance in laws (locals to international)    4  34.29   
3.2 Zoonotic potential    4  34.29   
3.3 Likelihood of occurrence   3   25.71   
3.4 Spread in humans  2    17.14   
3.5 Impact on human health   3   25.71   
3.6 Impact on food safety    4  34.29   
3.7 Bioterrorism potential  2    17.14   
4 Impact On Trade 1 2 3 4 5 10.00 60 
4.1 Impact on regional trade due to current laws  2    20.00   
4.2 Impact on national / EU trade due to current laws  2    20.00   
4.3 Impact on international trade due to current laws 1     10.00   
4.4 Potential for zoning 1     10.00   
5 Impact On Animal Welfare 1 2 3 4 5 2.86 54 
5.1 Potential impact on animal welfare (duration)    4  34.29 
  
5.2 Potential frequency of severe distress   3     
5.3 Severity / reversibility of the disease    4  11.43   
5.4 Impact on animal freedom   3   8.57   
6 Control Tools 1 2 3 4 5 5.00 60 
6.1 Proper tools for diagnosis  2    10.00   
6.2 Proper tools for prevention (within the region/area)    4  20.00   
6.3 Proper tools for control (within the region/area)   3   15.00   
6.4 Proper tools for therapy   3   15.00   
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 Summary Crit.   Coeff. Weight 
1 Relevance Of The Disease 64%   1 100 
2 Socio-Economic Impact 60%   2 200 
3 Impact On Public Health 63%   3 300 
4 Impact On Trade 30%   2 200 
5 Impact On Animal Welfare 54%   1 100 
6 Control Tools 60%   1 100 
 
 SCORECARD FORM [Last update 08-30-2013] 
Extra DISEASE INFORMATION 
E.1.1 Name of the disease 
Bovine mastitis (S. aureus). 
E.1.2 Aetiological agent/s  
Staphylococcus aureus. 
Gram-positive coccal bacterium; facultative anaerobic; asporigen; immobile; frequently β-haemolytic; 
catalase and coagulase positive (uncommon strains may not express coagulase). 
E.1.3 Brief description 
Bovine mastitis by S. aureus is common worldwide and represents one of the main cause of losses in 
cattle.  
S. aureus is a major agent of contagious mastitis, however, clinical cases were became less common in 
the last decade. Furthermore, these cases are usually mild or moderate. Subclinical cases represents 
the foremost source of losses within the herds.  
Contagious mastitis control is based on some key-points namely correct milking practices; segregation 
of infectious bovines; rational and aimed dry cow therapy; cull of subject with chronic infection. 
S. aureus can produce heat-stable enterotoxins (SE) that may induce food poisoning in humans. These 
toxicosis are usually mild and most patients recover after one to three days (in rare cases toxic shock 
is possible). Besides, S. aureus can colonize different species (human being included) without causing 
disease. 
1 RELEVANCE OF THE DISEASE 
1.1 
1.2 Presence and frequency of the disease within the region / outside the region 
1.1.1 
1.2.1 
Presence and frequency of the disease within the region 
In Lombardy region epidemiological data suggest a prevalence of S. aureus intra-mammary infections 
of 30% at farm-level and 12 – 15% at animal-level. 
In farms that sell raw milk for direct human consumption mandatory controls founded 2.9% of the 
bulk milk samples positive (>100 cfu/ml) for coagulase-positive staphylococci (CPS) in 2007 and 8.6% 
of samples in 2008. 
1.1.2 
1.2.2 
Presence and frequency of the disease within near region / country 
S. aureus mastitis represent a worldwide problem. In EU a German study founded a prevalence of 
21.8%; in Finland 10.1%; in Belgium 19%; in Netherlands 5 – 15% and in a Norway research over 60% 
of samples were found positive. 
1.1.3 
1.2.3 
Frequency of epidemics (specify where) 
Agent is widespread worldwide with different prevalence, without real epidemics in large areas. 
However, epidemics and endemics at farm-level are possible. 
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1.1.4 
1.2.4 
Animal Hosts / Vectors / Environment as source of disease 
Some strains are particularly adapted to invade mammary gland. In these strains the main source of 
contagion are infected quarters. Additionally, wounded teat skin and heifers (as reservoir or fomite) 
can be an important source of spread. 
S. aureus can colonize and invade a large number of animal species (human included). However, 
different species (other than cow) do not seem to have a relevant role in transmission of strains 
better adapted to infect the bovine mammary gland. These species may sporadically transmit other, 
less adapted, strains. 
Infection can be spread by flies as mechanical vector, though, the epidemiological importance of 
these arthropods is not clear yet (likely a minor role).  
Milking equipment represents the only relevant environmental source of disease. 
1.1.5 
1.2.5 
Seasonal cycles / outbreak influenced by climate anomalies 
Seasonal cycles do not seem to be influent for spread. 
Climatic anomalies, such as exceptional cold, may impair the natural barrier of teats and mammary 
gland and favour infections. 
1.1.6 
1.2.6 
Factors that facilitate the presence of the agent (scarce hygiene, biosafety, management, etc.) 
Overall: poor hygiene; inadequate management; animal movements (purchase of infected 
cows/heifers). 
Milking: poor milking hygiene; inadequate teats cup linear; poor milking practices. 
1.1.7 
1.2.7 
Stability of the agent within the environment 
High.  
S. aureus may survive for weeks in suitable environment. However, with exception of milking 
equipment, stability of the agent within the environment do not play an important role in spread. 
1.1.8 
1.2.8 
Likelihood of eradication  
None. 
S. aureus can colonize a large number of species without causing disease. Eradication of strains better 
adapted to infect the bovine mammary gland is possible at farm-level. 
1.3 Number of species involved 
1.3.1 Number of species involved (specify which ones) 
Bovine. 
S. aureus can be isolated from a huge number of domestic species such as water buffalo; sheep; goat; 
pig; equine; poultry; camelids; rodents; dog and cats. Furthermore, S. aureus represent a major cause 
of mastitis in sheep and  goats. However, strains from these species seem to be genetically different 
from strains particularly adapted to invade mammary gland and they are an uncommon cause of 
mastitis in cattle. 
1.4 Speed of spread 
1.4.1 Speed of spread within the farm 
Variable. Relatively fast in absence of control and adequate hygiene and management practices. 
1.4.2 Speed of spread between farms 
Variable. It depends on infected animal movements without control. 
1.4.3 Likelihood of spread without hosts movement outside the farm 
Unlikely / none. 
1.5 Vectors as reservoir and potential source of the disease 
1.5.1 Disease cycle influenced by vectors 
Flies can act as mechanical vector. The role of these arthropods is unclear, flies seem to be relevant in 
transmission only in areas where they can reproduce in large numbers without control. 
1.5.2 Presence of the vectors within the regional / national territory 
Not applicable (usually neglectable  for eradication at farm-level). 
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1.5.3 Presence of the vectors influenced by peculiar areas / climates 
Not applicable (usually neglectable  for eradication at farm-level). 
1.5.4 Vectors likelihood of survival, reproduction, spread the disease, act as reservoir 
Not applicable (usually neglectable  for eradication at farm-level). 
1.6 Risk of spread to susceptible species 
1.6.1 Likelihood of transmission 
Medium to high during milking without control of risk factors. Unlikely outside milking (for contagious 
mastitis). 
1.6.2 Route of transmission 
Mostly through indirect contact among cows during milking; transmission due to direct contact 
between mammary gland of different animals is unlikely. Heifers can act as reservoir or fomite. Other 
routes of transmission (from infection in different organs, from other species, through vectors) are 
sporadic and usually neglectable for eradication purposes at farm-level. 
1.6.3 Peculiar condition that influence transmission 
Poor hygiene; inadequate management; low biosecurity level (infected cows/heifers); inadequate 
milking practices. 
1.7 Wildlife as reservoir and potential source of the disease 
1.7.1 Species involved 
High number of species can be colonized or infected. However, strains from these species seem to be 
genetically different from strains particularly adapted to invade mammary gland and wildlife seems to 
be an unlikely source of infection. 
1.7.2 wildlife / livestock and pet / human interactions  
Not applicable. 
1.7.3 Endangered species involved 
Not applicable. 
1.8 Potential for silent spread 
1.8.1 Likelihood of recognition due to the clinical symptoms 
Very low.  
Clinical mastitis by S. aureus are uncommon in Lombardy (majority of cases remain subclinical) and 
the symptoms are not dissimilar to other clinical mastitis. 
1.8.2 Spread by subclinical / asymptomatic hosts  
High.  
Subclinical cases represent the majority of S. aureus mastitis and laboratory diagnosis (SCC and 
bacteriology) is mandatory. Furthermore, diagnosis can be difficult due to the low or intermittent 
shedding rates of S. aureus. 
1.8.3 Incubation time 
Variable (days to weeks). 
Clinical manifestations, when present, are dependent on single animal conditions, strain virulence and 
environment (stress). 
1.9 Variability of the agent 
1.9.1 Species / Types 
A large number of strains are known, these strains can colonize or infect a wide range of hosts and 
they can occupy various niches. Some strains are particularly adapted to invade mammary gland and 
have peculiar genetic characteristics. 
1.9.2 Mutations 
Common.  
Various studies has enlightened the genetic differences among strains that occupy diverse niches. 
Mutations that lead to SCV (small-colony variant) and MRSA (Methicillin-resistant Staphylococcus 
aureus) are matter of serious concern. 
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1.9.3 Number of hosts / vectors (host-specificity) 
Variable host-specificity. 
S. aureus can colonize a large number of hosts and vectors. Nevertheless, some strains seems to 
adapted to a specific “niche” (e.g. mammary glands) and they may rarely isolated outside their niche. 
Genetic characteristics of these strains and how they interact with different hosts need further 
investigations. The relevance of “genetic information” shift between human and bovine strains are 
not fully known; this shift need to be further clarified due to the growing antibiotic resistances and 
isolation of MRSA. 
1.10 Knowledge of host-pathogen interaction 
1.10.1 Status of knowledge of host-pathogen interaction 
Partial.  
S. aureus ability to colonize bovine mammary gland; to invade the epithelium and to localize within 
the interstices are matters of particular interest due to the negative consequences on therapy. 
Besides, S. aureus can infect the mammary gland without visible symptoms but with an important 
increase in SCC and cause relevant economic losses. 
Some genetic characteristics and how they affect host-pathogen interaction are still unclear. The role 
of heifers in spread needs further investigations. Host-specificity, host shift and adaptation 
capabilities of different strains are only partially known. 
Some virulence factors remain unidentified; in order to improve Status of knowledge of host-
pathogen interaction and possible vaccines a better knowledge of these virulence factor and their 
regulation are required. 
1.11 Knowledge of immunology 
1.11.1 Complete / partial / absent knowledge of humoral immunity 
Partial.  
Humoral immunity does not seem to have relevant in protection against mammary gland infection 
and it poses a great limitation in killed vaccine development. Roles of neutralising antibody and 
humoral-cellular immunity interactions in mammary gland protection need further investigation. 
1.11.2 Complete / partial / absent knowledge of cellular immunity 
Partial.  
Role of cellular immunity in pathogenesis and protection needs further investigations. 
2 SOCIO-ECONOMIC IMPACT 
2.1 Impact on production within the region 
2.1.1 Production losses  
Mastitis represents one of the major causes of economic losses in cattle. In Lombardy, production 
drop due to the disease determines losses for 2 million of euros per year. Costs of subclinical mastitis 
are 60 – 350€ per cattle; in clinical cases 136 – 267€ represent the expenses for therapy. 
Direct losses: 
− Drop of milk production 
− Reduction of milk quality 
− Infected milk waste or due to suspension time (therapy) 
− Cull of cows with chronic infection / refractory to therapy + replacement expenses 
− Drop of cheese yield 
− Mortality (uncommon in S. aureus mastitis) 
Indirect losses: 
− Routine expenses (e.g. feed) for cows with less milk yield or with waste milk 
− Drop of reproductive performances 
− Loss of future income due to cull / drying-off mammary quarters infected with staphylococcus 
aureus 
Furthermore, outcomes for veterinary interventions (visit, diagnosis and therapy); costs linked to 
control plans (if present) and ban of product (e.g. raw milk). 
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2.1.2 Quality losses 
Relevant quality losses of milk: 
− Increase in somatic cells count (drop in milk price and interference with cheese production) 
− Drop in lactose yield (5-20%) 
− Drop in casein yield (6-18%) 
− Drop in fat yield (5-12%) 
− Reduction of mineral salt (Ca, P e K) 
Furthermore, plasminogen concentration in milk can increase due to mammary gland infections, 
rennet activates plasminogen in plasmin during cheese production and plasmin reduces concentration 
of k-casein, which may result in a delayed curd formation. 
The increase of γ-globulin in milk, during intramammary infections, impairs thermic stability of milk 
and may alter cheese production processes. 
2.1.3 Menace to survival of livestock industry 
None.  
Economic impact is significant; however, the disease does not menace survival of livestock industry 
(only sole farms). 
2.2 Economic impact of the control plan 
2.2.1 Voluntary / mandatory control plan 
No official plan available in Lombardy (neither mandatory nor voluntary).  
Some farmers implemented a plan of eradication on a voluntary basis. 
2.2.2 Actual cost of the surveillance 
Not applicable. 
2.2.3 Outbreak within the region (per year) 
Not applicable. 
2.2.4 Adopted control measures and actual costs 
Not applicable. 
2.3 Potential economic direct impact 
2.3.1 Production and movement limited / banned 
Suspension or ban if raw milk for direct human consumption   does not comply with the law  (Circ. 
19/SAN/07). 
2.3.2 Potential economic cost 
Losses in milk yield can be significant, namely, 150 – 300 litres per cows. Furthermore, infected cows 
may undergo delay in first heat; fertility drop; higher risk of foetal death. Besides, cows with a 
previous clinical mastitis can present reduction in reproductive performances (excessive days open). 
2.3.3 Control strategies available (vaccination and therapy / Test-and-cull / Stamping out) 
Several strategies are available: 
− High standards in biosecurity, hygiene and management (pivotal pre-requisite for control, the 
costs may vary). 
− Dry and/or Milking therapy (ineffective alone at farm-level and inconsistent results even at 
animal-level)  
− Vaccination (poor efficacy for bovine mastitis by S. aureus). 
− Eradication plan based only on “test-and-cull” (unsustainable with high prevalence). 
− Eradication plan based on segregation (effective when applicable). 
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2.3.4 Costs of intervention (surveillance and control) 
Low for screening (bulk milk).  
In a rational and effective eradication plan cost of surveillance should be around 100€ per cows every 
year (average duration 2 years).  
Expenses of control may vary. Outcomes for culling in a farm with high prevalence are huge. Costs of 
therapy during milk are commonly 136 – 267€ per clinical case; expenses of ration dry cow therapy 
should be about 10€ per cow. 
Costs of an adequate control plan can be high, they depends on prevalence of infection and status of 
farm (biosecurity, hygiene and management). However, the costs/benefit ratio is favourable on the 
long-run. 
2.4 Potential economic indirect impact 
2.4.1 Consequences on the distribution of the products 
Mild / None.  
Consequences only on the distribution of raw milk for direct human consumption. 
2.4.2 Market value losses 
Neglectable (at the moment).  
Potential market value losses due to fear of the disease caused by media is unlikely. Nevertheless, if 
severe S. aureus infections in humans (i.e. hospital-acquired) will gain more exposure, potential losses 
in milk sales will be possible even if intramammary infections by S. aureus in cows are totally 
unrelated. Furthermore, negative economic indirect losses will be conceivable if bovine S. aureus will 
show a more relevant role in MRSA epidemiology and/or as a source of antibiotic-resistant strains for 
humans. 
2.4.3 Nation-wide ban of distribution 
None. 
2.4.4 Cost of treatments and control of the disease in humans 
Low.  
Food poising due to ingestion of SE is usually not severe and self-heal is frequent, hospitalization is 
rarely required. 
Hospital-acquired infections caused by S. aureus can be severe (sepsis and/or encephalitis) and may 
result in death,  hospitalization is required and the cost of treatments is usually high. However, these 
infections and bovine mastitis by S. aureus are not related. 
2.4.5 Tourism losses and menace to biodiversity 
Never described. 
2.4.6 Restriction on the entire productive system 
None. 
3 IMPACT ON PUBLIC HEALTH 
3.1 Relevance in laws (locals to international) 
3.1.1 Relevance in laws (region / nation / EU / worldwide)  
EU-wide. 
3.2 Zoonotic potential 
3.2.1 Possibility of transmission between animals and humans (yes / no / unclear) 
Low.   
Bovine strains rarely infect humans; however, food poisoning due to S. aureus toxins is likely to be 
common. 
3.2.2 Likelihood of transmission between animals and humans 
Low but exact frequency is unknown. Food poisoning due to SE is not uncommon, nonetheless, 
epidemiology estimations are difficult because other coagulase-positive staphylococci (CNS), like S. 
intermedius and S. hyicus (although sometimes they do not express coagulase), may produce SE and 
lead to misdiagnosis. CNS do not seem to play a relevant role in SE food poisoning. 
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3.2.3 Route of transmission from animals to humans (direct, indirect; vector, food, environment, airborne) 
Infections: Direct contact with infected cows. 
Poisoning: Ingestion of contaminated food or direct contact if mucosae is accidentally exposed to 
Staphylococcal enterotoxin B (SEB). 
3.2.4 Species barrier 
Medium barriers for infections (different strains in diverse species). None for food poisoning. 
3.2.5 Virulence factors 
Plenty virulence factors are known, others are still putative. Additionally, expression and regulation of 
virulence factors need further investigations. 
Virulence of different strains is correlated to their ability of produce toxins and certain cell-wall 
molecules. The most important virulence factors are: 
− Enterotoxins (SEs), large number of superantigens, SEB is one of the most dangerous for 
humans. 
− Superantigen-like proteins (SSLs), host immune evasion/modulation; molecular structure 
similar to SEs without superantigen activity and no/unknown gastro-enteric toxicity. 
− Exfoliative toxins (EFA and EFB), proteases pivotal for cutaneous infections.  
− Leukocidin PV (Panton-Valentine), pore-forming toxin, one of the key factors for necrotizing 
pneumonia. Common in MRSA strains. 
− Protein A, binds IgG and inhibits phagocytosis. 
− Penicillin-binding protein 2a (PB2a), encoded by mecA gene, provides β-Lactam antibiotic 
résistance. 
− Fibronectin-binding protein, facilitates host invasion. 
− Coagulase, facilitates host invasion, important for bacteriological and molecular diagnosis. 
− Capsular polysaccharides, permits phagocytosis resistance, host adhesion and biofilm 
formation. 
− Other toxins (alpha-toxin, beta-haemolysins, gamma--haemolysins, delta-haemolysins). 
− Other enzymes (proteases A-F, endopeptidase V8, hyaluronidase, staphylokinase). 
− Biofilm, (complex agglomerate of bacteria cells, organic matrix and water), adhesion to 
various surfaces and protective environment against host defences and antibiotics. 
3.2.6 Likelihood of underestimate human cases 
Food poisoning by S. aureus toxins is likely to be underestimated due to its evolution. in particular, 
these poisonings usually present mild to medium non-specific symptoms and quick self-heal is 
common. 
3.3 Likelihood of occurrence 
3.3.1 Probability of occurrence 
Very low for infections, relatively high for food poisonings.  
For example, in 1993-‘98 WHO reported 574 outbreaks in different European states (French, 
Germany, Switzerland, Spain, Portugal and countries of Scandinavia); Spain and French suffered the 
larger number of outbreaks. 
3.4 Spread in humans 
3.4.1 Likelihood of transmission between humans 
Unlikely for strains particularly adapted to invade mammary gland (possible for human strains). 
None for food poisonings. 
3.4.2 Route of transmission between humans (direct, indirect) 
Not applicable (direct and indirect for human strains). 
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3.5 Impact on human health 
3.5.1 Severity of the disease 
Mild to medium for food poison. Symptoms like nausea, abdominal pain, vomit and diarrhoea appear 
1 - 6 hours after ingestion. SEB accidental inhalation causes both respiratory (cough, dyspnoea, 
thoracic pain) and general (fever, muscular pain, cephalea) symptoms. 
Hospital-acquired infections may be severe and lead to shock, neurological damages and deaths. 
However, these infection are unrelated to bovine mastitis. 
3.5.2 Symptoms duration and time off work length 
Commonly 1 - 2 days for food poisoning. Toxic shock usually requires long hospitalization; however, is 
rare. 
3.5.3 Permanent damages 
Commonly none for food poison.  
Accidental inhalation of high dose of SEB may causes permanent damages (organs with filter functions 
and brain). 
3.5.4 Mortality 
Very rare for food poison (common in hospital-acquired infections). 
3.6 Impact on food safety 
3.6.1 Likelihood of infection / intoxication due to infected / contaminated food 
Neglectable for infections but high for intoxication of SEs.  
Potential sources of contamination are contaminated milk, dairy products (heath-stable toxins) and 
cross-contaminated foods that allow S. aureus growth. SEs are hydro-soluble proteins with 
superantigen activity; precisely, SEs can bypass normal ways of antigen presentation, directly 
stimulate T-helper lymphocytes and lead to a massive production of cytokines. Moreover, SEB act as a 
strong pyrogenic agent in humans, especially when inhaled.  
Gastro-enteric symptoms are prevalent due to ingestion of SEs while respiratory signs are 
predominant if inhaled. 
3.6.2 Infectious / toxic dose 
Low.  
10 – 50 ppm in food are enough to cause symptoms. Toxins production is linked to various factors 
such as strain; temperatures (growth range 10 – 45°C, optimum 37 – 40°C); pH (5.15 – 9.0) and 
nutrients available. 
3.6.3 Mandatory precautions 
Raw milk for direct human consumption must have less than 100 cfu/ml of CPS (19/SAN/07).  
For food safety sake it’s important to remind that some SEs are heat-stable and may remain active 
even after a 30 minute boiling, they are resistant to main proteases (trypsin,  chymotrypsin, rennin 
and papain) and may resist radiation too. 
3.7 Bioterrorism potential 
3.7.1 Potential to cause substantial harm in humans 
Neglectable.  
Stains adapted to mammary glands infections are genetically different to humans strains and they are 
an unlikely source of infection. SEs are usually responsible of mild food poisoning.  
SEB represent the only exception and it may have a potential application in bioterrorism, it is included 
in category B of Bioterrorism Agents/Diseases List by CDC. 
3.7.2 Agent availability 
Neglectable for stains that cause bovine mastitis. 
3.7.3 Facility of use and conservation (Labs / trained professionals / sole person) 
Neglectable for stains that cause bovine mastitis. SEB production and purification require specific 
expertise and adequate equipment. SEB is stable in environment and easy to store however it’s 
application in a large scale bio-warfare should be limited due to the production limits. It may be used 
for a small attack in order to receive a great deal of media attention. 
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4 IMPACT ON TRADE 
4.1 Impact on regional trade due to current laws 
4.1.1 Ban / Limitations on trade (positive animal only, herd, limited area, region-wide) 
None for animal trade.  
4.1.2 List of banned products 
Suspension or ban if raw milk for direct human consumption   does not comply with the law (Circ. 
19/SAN/07). 
4.1.3 Free-status loss 
Suspension / revocation of license to sell raw milk for direct human consumption. 
4.1.4 Difficulty and time needed to regain free-status 
Variable, dependent on how quick the milk comply again with the law. 
4.2 Impact on national / EU trade due to current laws 
4.2.1 Ban / Limitations on trade (positive animal only, herd, limited area, nation-wide) 
None. 
4.2.2 List of banned products 
Products that do not comply with the law (EC 2073/2005). 
4.2.3 Free-status loss 
Not applicable (Italy has not free-status). 
4.3 Impact on international trade due to current laws 
4.3.1 Ban / Limitations on trade (positive animal only, herd, limited area, nation-wide or EU-wide) 
None. 
4.3.2 List of banned products 
Products that do not comply with the law (EC 2073/2005). 
4.3.3 Free-status loss 
Not applicable (Italy has not free-status). 
4.3.5 Countries with particularly strict laws (about the disease) 
None. 
4.4 Potential for zoning 
4.4.1 Zone of control size 
Not applicable (no official control plan in Lombardy). 
5 IMPACT ON ANIMAL WELFARE 
5.1 Potential impact on animal welfare (duration) 
5.1.1 Presence and duration of animal welfare damages 
Usually mild/medium clinical mastitis with symptoms for few days. These mastitis may evolve in 
chronic forms that are commonly subclinical. 
5.2 Potential frequency of severe distress 
5.2.1 Percentage of animal with severe distress 
Variable (usually none).  
In Lombardy, clinical mastitis by S. aureus are far less frequent than subclinical ones. Furthermore, 
severe clinical cases are really uncommon. Infected cows with distress, particularly during milking, 
may pass unnoticed. 
5.3 Severity / reversibility of the disease 
5.3.1 Severity of the disease and reversibility of the damages 
Variable. Severe clinical cases are unusual; however, selfheal is rare too. 
Evolution from both clinical and subclinical infections to chronic mastitis is possible; chronic infected 
cows may be subject to irreversible damages at mammary gland such as fibrosis, abscesses and 
obstruction of teats sphincter. 
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5.3.2 Available therapies and their effectiveness 
Variable.  
Antibiotics during milking may be ineffective (depends on quickness). Accurate dry cow therapy 
represents the most effective treatment. 
Peracute mastitis by S. aureus are rare; nonetheless, they usually lead to death or cull even with 
proper treatment (antibiotic, FANS and drip feed). 
5.4 Impact on animal freedom 
5.4.1 Potential restriction on the “Five Freedom” (freedom from fear and distress NOT included) 
Restriction on Freedoms: 
− From pain, injury or disease 
− To express normal behaviour (fertility problems). 
6 CONTROL TOOLS 
6.1 Proper tools for diagnosis 
6.1.1 Validated kits availability within the nation  
Not applicable. 
6.1.2 Laws that rule the surveillance 
Mandatory surveillance for farms that sell raw milk for direct human consumption: 
− Bacteriological tests (CPS must be < 100 UFC/ml) 
Sampling and test are performed by IZS della Lombardia e dell’Emilia Romagna, as stated in the 
related law (circ. 19/SAN/07). 
Regulation (EC) No 2073/2005 on microbiological criteria for foodstuffs establishes: 
− CPS in Milk and milk powder, n = 5,  c = 2, m = 10 cfu/g and M = 100 cfu/g 
− Absence of staphylococcal enterotoxins in cheese and milk powder (mandatory control if CPS 
> 105 cfu/g), n = 5 (25g each sample) 
6.1.3 Techniques described by international organisation (OIE, WHO, UE, etc.) 
Regulation (EC) No 2073/2005: 
− ELISA for enterotoxins (reference EU lab) 
− BACTEORIOLOGICAL EXAM for CPS following ISO 6888-1 (agar Baird-Parker) or ISO 6888-2 
(agar RPF) Standards. 
6.1.4 DIVA test possibility / obligation of use  
None. 
6.1.5 Overall judgement on tools for control 
Control and eradication are possible at farm-level; a mandatory eradication plan for a large 
geographical area should be carefully evaluated (epidemiological status, costs/benefits and 
organizational problems). 
High standards in biosecurity, management and hygiene are required even before the 
implementation of a control plan. Particular care should be taken in milking practices and cows turn-
over (heifers and purchased animals). Where eradication is not possible farms remain exposed to 
introduction of new strains and the risk of peak of new infections due to climate anomalies 
(exceptional cold may impair the natural barriers of teats and mammary gland). 
An eradication plan based on segregation of infected cows and cull of chronic infected bovines 
(unresponsive to treatment) presents a favourable cost/benefits ratio on a long period. However, 
previous mentioned pre-conditions must be satisfied for a successful plan, besides, a reliable protocol 
in both diagnostic (samples, identification of infected/uninfected, surveillance)  and therapy (targeted 
dry cow therapy and antibiotics during milking) are necessary.  
Control plans based only on culling may provide varying results and they are less effective than 
segregation strategies. 
Vaccination, where available, does not seem to be trustworthy for prevention of new infections. 
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6.2 Proper tools for prevention (within the region/area) 
6.2.1 Obstacles / incentives to prevention 
Obstacles − Relevant investments at the beginning of program (economic and management); farmer 
sustains all the expenses for control plan; required high level of coordination and collaboration among 
farmer, veterinary and laboratory; unavailability of a reliable and cheap on-farm test; vaccination 
largely ineffective; technical difficulties in management of groups for segregation; very difficult with 
automatic milking systems. 
Incentives – Advantageous income/outcome with a proper control plan; required for eradication; 
mandatory in farms that sell raw milk for direct human consumption. 
6.2.2 Available prevention strategies and their efficacy 
High standards in biosecurity, management and hygiene are effective in control and prevention 
(spread within the herd and from purchased cows/heifers). 
Segregation of infected cows and milking groups based on health status can be effective in prevention 
and control only if properly managed. 
Vaccination provides inconsistent results and it is usually ineffective for control and prevention. 
6.2.3 Commercial vaccines availability in EU / Worldwide 
Only two killed vaccine are available for bovine mastitis by S. aureus:  
− StarVac® (Hipra), available in EU. 
− Lysigin® (Boehringer Ingelheim), a lysed culture of polyvalent somatic antigen available in 
North America. 
6.2.4 Marker vaccines availability in EU / Worldwide 
None. 
6.2.5 Vaccination efficacy 
Essentially ineffective. 
Commercial vaccines are composed of the whole killed bacterium. Killed vaccines stimulate almost 
only humoral immunity (already present even in healthy cows) that seems to be widely ineffective 
versus S. aureus mastitis. Furthermore, milk may interfere with antibodies activity, some virulence 
factors are still unknown (possible future targets of vaccination), relevant variances among strains in 
different farm and geographical areas, and thus, effective vaccines are difficult to develop (adjuvants 
included). 
Field studies in several countries observed inconsistent results, in some cases the vaccines were 
effective in other not.  
New types of vaccine are under study, with different approach. For example, DNA vaccine seems to 
be promising because of their capability to induce a cellular immunity without stress. 
6.2.6 Laws that rule vaccination 
Not applicable (no official control plan in Lombardy). 
6.3 Proper tools for control (within the region/area) 
6.3.1 Obstacles / Incentives to control 
Obstacles − Relevant investments at the beginning of program (economic and management); farmer 
sustains all the expenses for control plan; required high level of coordination and collaboration among 
farmer, veterinary and laboratory; unavailability of a reliable and cheap on-farm test; vaccination 
largely ineffective; technical difficulties in management of groups for segregation; very difficult with 
automatic milking systems. 
Incentives – Advantageous income/outcome with a proper control plan; mandatory in farms that sell 
raw milk for direct human consumption. 
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6.3.2 Available control strategies and their efficacy 
Hygiene, biosecurity and appropriate management are pivotal in control plans.  
Cull of infected cows, as sole control strategy, is usually unsuccessful. A control/eradication plan 
based on  segregation is commonly successful in farms where it can find a proper application. 
Dry cow therapy is essential in an effective control plan while therapy during milk should be carefully 
evaluated.  
Vaccination seems to be ineffective. 
6.3.3 Laws that rule control strategy 
Mandatory surveillance for farms that sell raw milk for direct human consumption (circ. 19/SAN/07). 
6.4 Proper tools for therapy 
6.4.1 Therapeutic protocol in use (cure and prophylaxis) 
Antibiotics for milking cows and, when needed, FANS and drip feed. 
Dry cow therapy with proper antibiotics (more successful in S. aureus mastitis). 
6.4.2 Laws that rule therapies 
Suspension time required after therapy (length depending on drugs used). 
6.4.3 Residual risks / suspension time 
Residual risk in milk if suspension time is not followed (usually 2 – 4 days) or with antibiotics misuses 
(administration of antibiotics for dry period during milking).  
Residual risk in meat if in culled cows (refractory to therapy) suspension time is not followed. 
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Appendix C: Bluetongue 
 
SCORECARD [last update 12-15-2012] 
BLUETONGUE  SCORE = 499 
Criteria Score Coef Total 
1 Relevance Of The Disease 1 2 3 4 5 1.43 52.9 
1.1 Presence of the disease     3     
4.29 
  
1.2 Frequency of the disease 1           
1.3 Number of species involved       4   5.71   
1.4 Speed of spread         5 7.14   
1.5 Vectors as reservoir and potential source of the disease         5 7.14   
1.6 Risk of spread to susceptible species         5 7.14   
1.7 Wildlife as reservoir and potential source of the disease       4   5.71   
1.8 Potential for silent spread     3     4.29   
1.9 Variability of the agent       4   5.71   
1.10 Knowledge of host-pathogen interaction   2       2.86   
1.11 Knowledge of immunology   2       2.86   
2 Socio-Economic Impact 1 2 3 4 5 10.00 120 
2.1 Impact on production within the region 1         10.00   
2.2 Economic impact of the control plan   2       20.00   
2.3 Potential economic direct impact         5 50.00   
2.4 Potential economic indirect impact       4   40.00   
3 Impact On Public Health 1 2 3 4 5 8.57 60 
3.1 Relevance in laws (locals to international) 1         8.57   
3.2 Zoonotic potential 1         8.57   
3.3 Likelihood of occurrence 1         8.57   
3.4 Spread in humans 1         8.57   
3.5 Impact on human health 1         8.57   
3.6 Impact on food safety 1         8.57   
3.7 Bioterrorism potential 1         8.57   
4 Impact On Trade 1 2 3 4 5 10 130 
4.1 Impact on regional trade due to current laws     3     30   
4.2 Impact on national / EU trade due to current laws     3     30   
4.3 Impact on international trade due to current laws     3     30   
4.4 Potential for zoning       4   40   
5 Impact On Animal Welfare 1 2 3 4 5 2.86 71 
5.1 Potential impact on animal welfare (duration)     3     
42.86 
  
5.2 Potential frequency of severe distress         5   
5.3 Severity / reversibility of the disease         5 14.29   
5.4 Impact on animal freedom         5 14.29   
6 Control Tools 1 2 3 4 5 5 65 
6.1 Proper tools for diagnosis   2       10   
6.2 Proper tools for prevention (within the region/area)       4   20   
6.3 Proper tools for control (within the region/area)     3     15   
6.4 Proper tools for therapy       4   20   
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 Summary Crit.   Coeff Weight 
1 Relevance Of The Disease 53%   1 100 
2 Socio-Economic Impact 60%   2 200 
3 Impact On Public Health 20%   3 300 
4 Impact On Trade 65%   2 200 
5 Impact On Animal Welfare 71%   1 100 
6 Control Tools 65%   1 100 
 
 
 SCORECARD FORM [last update 12-15-2012] 
Extra Disease 
E.1.1 Name of the disease 
Bluetongue (ovine catarrhal fever) 
E.1.2 Aetiological agent/s  
Bluetongue virus (BTV), a double-stranded RNA virus without envelope, member of the genus 
Orbivirus, family Reoviridae. At the moment there are 24 known BTV serotypes. Genus Orbivirus 
comprises 20 different but related virus. BTV shows close correlation to the serogroup of virus that 
cause epizootic haemorrhagic disease (EHD) in deer. 
E.1.3 Brief description 
BTV may infect several ruminants such as sheep, goats, cattle, water buffaloes, and various species of 
deer and antelopes; although rare, BTV may also infect other species. 
Biting midges of the genus Culicoides act as biological vectors and are the main responsible of BTV 
spread, indeed, the occurrence of bluetongue in a geographical area is always associated with the 
presence of these vectors. Other route of transmission are possible (needles, surgical equipment, bull 
semen) but very unlikely.  
In the majority of affected species BTV infections are asymptomatic; however, in sheep, deer and 
antelopes the diseases can be severe with serious distress and high mortality rates (up to 90%). Goats 
and cattle (BTV-8 infections only) may develop clinical forms but symptoms are usually mild and 
mortality is rare. Moreover, cattle are the most important amplifying host because of their prolonged 
viraemia (up to 3 months). 
Symptoms of bluetongue in sensitive species are often severe and they may include fever, depression, 
anorexia, excessive salivation, oedema, dyspnoea, nasal discharges, affected mucosae may be 
hyperaemic, cyanotic and/or ulcerated. Other gastro-intestinal or respiratory symptoms may also 
occur. 
Diagnosis is usually based on serological tests and isolation of the virus.  
The main control strategies are vaccination, biosecurity, control of midges and animal transfers. 
Bluetongue is not a zoonosis and BTV do not represent a significant threat for human health; 
nevertheless, one case of infection has been reported in a laboratory technician and a minimum level 
of security should be adopted while working with BTV. 
1 RELEVANCE OF THE DISEASE 
1.1 
1.2 Presence and frequency of the disease within the region / outside the region  
1.1.1 
1.2.1 
Presence and frequency of the disease within the region 
None. All the province within Lombardy are declared free for the season (12.19.2010 to 02.23.2011) 
by the Health Ministry. In Lombardy are active both a serological surveillance plan (farm with sentinel 
cattle and slaughterhouse) and an entomological surveillance plan (fixed and mobile traps). In 
Lombardy, at the moment, the mandatory vaccination plan is not active. The last mandatory 
vaccination campaign was in Mantova province during 2009 due to an outbreak of BTV-8 in Veneto 
region (“decreto direzione generale sanità n. 7209 del 02/07/2008”). 
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1.1.2 
1.2.2 
Presence and frequency of the disease within near region / country 
BTV-1, 2, 4, 8, 9 and 16 are the serotypes present in Italy, with different distributions among Italian 
regions. During the last few years several outbreaks occurred in Italy: 
− 2002: 392 outbreaks (Sardinia, Molise, Puglia, Basilicata, Calabria, Sicily, Lazio, Campania) 
− 2003: 3,730 outbreaks (one in Sicily the others in Sardinia). 
− 2004: 131 outbreaks (Sardinia). 
− 2006: 238 outbreaks (one in Sicily the others in in Sardinia). 
− 2007: 19 outbreaks (Veneto e Sardinia). 
− 2008: 61 outbreaks (Veneto, Piedmont, Sardinia, Sicily). 
− 2009: 20 outbreaks (Veneto, Sardinia, Sicily, Campania). 
− 2010: 36 outbreaks (Sardinia, Sicily, Campania). 
− 2011: 446 outbreaks (440 in Sardinia the others in Sicily and Campania). 
During the last few years outbreaks occurred in all the neighbour Countries. 
1.1.3 
1.2.3 
Frequency of epidemics (specify where) 
Within EU outbreaks were uncommon and occurred only in Mediterranean Countries until the end of 
the nineties. Since 1998 outbreaks and even epidemics became more frequent in Mediterranean area, 
finally, in 2006 the first epidemic occurred in Northerner European Countries. Precisely: 
− 1998: an epidemic of bluetongue started in Greece and spread within Mediterranean area. 
− 2000: BTV-2 in Sicily, Sardinia, and Calabria (also BTV-9). In Sardinia, over 260,000 sheep were 
culled or died during this epidemic.  
− 2001: large epidemic in Italy (ended in April 2002), over 250,000 sheep were culled or died 
during this epidemic. 
− 2003: BTV-4 in Sardinia (3,729 outbreaks).  
− 2006: BTV-8 epidemic (over 2,000 outbreaks) started in Netherlands then spread in Germany, 
Belgium, Luxembourg, and France (bovines were affected too). 
− 2007: BTV-8 in North European Countries with over 40,000 outbreaks. 
− 2008: BTV-8 in France with about 38,000 outbreaks. 
1.1.4 
1.2.4 
Animal Hosts / Vectors / Environment as source of disease 
Affected hosts are susceptible to the disease with different degree, depending on species and breed. 
Cattle may play a central role (amplifying hosts) in spread of bluetongue due to their prolonged 
viraemia generally without symptoms. The epidemiological role of Artiodactyla (other than 
ruminants) is still unclear. 
The presence of bluetongue in a geographical area is possible only if its biological vector is present, 
particularity female biting midges of various species of Culicoides. 
Although BTV may be persist in a favourable environment for a long period, environmental 
contamination do not has a relevant role in bluetongue epidemiology. On the other hand, a 
favourable environment (puddles, wet-warm climate) is pivotal for the presence of BTV vectors. 
1.1.5 
1.2.5 
Seasonal cycles / outbreak influenced by climate anomalies 
Seasonal cycles can influence feeding and mating activities of biological vectors (adult females of 
Culicoides). These cycles are correlated to climate and are typically observed when the disease is 
present at northern latitudes (north of Italy, France, Germany, etc.). 
Climate anomalies, such as excessive rain and abnormal temperature peaks, may alter seasonal cycles 
and promote the diffusion of the vectors. 
1.1.6 
1.2.6 
Factors that facilitate the presence of the agent (scarce hygiene, biosafety, management, etc.) 
Poor levels of biosecurity. Inadequate control of animal transfers (areas at risk); inadequate control of 
biological vectors; favourable environment for vectors (wet-warm climate for feeding, presence of 
wet areas for mating); absence of a proper epidemiological surveillance; presence of susceptible 
species, amplifying hosts and biological vectors in the same area. 
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1.1.7 
1.2.7 
Stability of the agent within the environment 
Neglectable because of the routes of transmission of the diseases. 
[The virus may persist within favourable environments for years. BTV is inactivated by low (<6) or high 
(>8) pH, high temperature (50°C for three hours or 60°C for 15 minutes) and proper disinfectants] 
1.1.8 
1.2.8 
Likelihood of eradication  
Possible. Likelihood of eradication is correlated to the presence of the vectors, amplifying hosts and 
wild hosts. 
1.3 Number of species involved 
1.3.1 Number of species involved (specify which ones) 
High. Sheep, goats, cattle, buffaloes, deer and domestic camelids. BTV infections are also described in 
dogs due to an accidental contamination of vaccines for pet. 
1.4 Speed of spread 
1.4.1 Speed of spread within the farm 
Variable (depending on control measures and vectors diffusion).  
In sheep bluetongue, without control measures, may spread very fast and morbidity can reach 100%. 
1.4.2 Speed of spread between farms 
Variable (depending on control measures and vectors diffusion).  
In sheep bluetongue, without control measures, may spread very fast and morbidity can reach 100%. 
1.4.3 Likelihood of spread without hosts movement outside the farm 
Variable (depending on control measures and vectors diffusion). 
In absence of effective control measures BTV can rapidly spread among farms without host 
movements throughout biological vectors. Biting midges of Culicoides spp. tend to live relatively near 
the area where they were born; however, winds may transport these vector for several kilometres. 
Some Authors speculated that, during the early 2000, BTV-8 were transported by the wind from North 
Africa to Sardinia and Balearic Islands (similar to sand carried by the wind to these island after sand 
storms in Africa). 
1.5 Vectors as reservoir and potential source of the disease 
1.5.1 Disease cycle influenced by vectors 
Yes, endemic areas and natural outbreaks are possible only where the vectors are present. 
Biting midges of the genus Culicoides act as BTV biological vector. Genus Culicoides includes over 
1,400 species (almost all haematophagous) but only a minor fraction of these species can spread BTV 
(different species may also spread diverse BTV serotypes). 
1.5.2 Presence of the vectors within the regional / national territory 
The vectors are present in Lombardy and in other parts of Italy (where climate is favourable). 
C. imicola is the characteristic vector of BTV of African origins and, before 1998, bluetongue outbreaks 
were related only to C. imicola presence. After 1998, BTV were also isolated from different species, 
belonging to pulicaris or obsletus complexes (although only 0.4% of individuals within these complex 
seems able to act as vector). 
1.5.3 Presence of the vectors influenced by peculiar areas / climates 
The presence of the vector is correlated to warm temperature, high humidity and availability of wet 
areas for reproduction. 
Vectors are active (mating and feeding) during all the year in tropical areas, in temperate areas their 
activities follow seasonal cycles (favourable climate). 
Low temperatures have a negative impact on survival of the vectors; according to experimental data 
the vitality of C. imicola eggs begins to decrease after a week at 6.5°C and reach zero after 37 days; 
however, some adults (about 15%) may survive even at -1.5°C for 15 days. 
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1.5.4 Vectors likelihood of survival, reproduction, spread the disease, act as reservoir 
Culicoides spp. is able to colonize and survive in areas with favourable climate and environment. 
The vector, afterwards the blood meal, cannot infect the host before 7 to 10 days (intrinsic incubation 
period), after this period it will remain infectious during its entire lifespan. Life expectancy of the 
vector is usually brief, 10 to 20 days, however, some females midges may survive up to 90 days, and 
thus, they can have a large number of blood meals. 
The vectors are typically active from the dusk till the first hours of the dawn but their activities cease 
in case of adverse conditions (low humidity, temperature < 12°C, wind > 3m/s, rain, complete 
darkness). High temperatures promote BTV replication within the vector and reduce the intrinsic 
incubation period, as the temperatures decrease virus replication slows-down and incubation period 
increases (under 15°C the spread the disease by vectors tends to stop). 
The presence of the vectors is mandatory for BTV spread, nonetheless, there is no evidence of 
transovarial transmission of the virus in Culicoides spp.. 
1.6 Risk of spread to susceptible species 
1.6.1 Likelihood of transmission 
High in absence of control (in unvaccinated sheep morbidity may reach 100% if vectors are not 
controlled). 
1.6.2 Route of transmission 
Various route of transmission are reported: 
− Transmission by vector (adult females) only during the blood meal (primary source of spread). 
− Transmission to new-borns ruminants due to infected colostrum is described, however, the 
epidemiological relevance of this route of transmission is not clear. 
− Venereal transmission is possible in ruminants and, in cattle, transplacental transmission is 
also reported (BTV-8). 
− In dogs described cases of infection due to contaminated vaccines and in lynx via infected 
meat (BTV-8). 
1.6.3 Peculiar condition that influence transmission 
Several condition can promote spread of the disease: 
− Poor biosecurity and lack of surveillance. 
− Poor control of movements of potential hosts. 
− Poor control of potential vectors. 
− Simultaneous presence of amplifying and sensible hosts within areas at risk. 
− Entrance of BTV in areas where the potential hosts are not immunised. 
− Temperature peaks and high humidity. 
1.7 Wildlife as reservoir and potential source of the disease 
1.7.1 Species involved 
High.  
Wild ruminants and other Artiodactyla (e.g. camelids) can be infected, however, these animals usually 
develop asymptomatic infections. Exceptions are: mouflons (mild symptoms and very low mortality), 
white-tailed deer (severe disease with haemorrhagic fever and high mortality), pronghorn antelopes 
(severe disease with haemorrhagic fever and high mortality), and New World camelids (mild 
symptoms and very low mortality). 
Seroconversion without symptoms is described in some wild carnivorous, and mortality is reported in 
Eurasian lynx due to ingestion of infected meat (BTV-8). 
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1.7.2 wildlife / livestock and pet / human interactions  
Epidemiological role of wildlife, especially in Lombardy and similar areas, is not well clear and further 
researches are needed (in some wild ruminant species in various areas of Africa and North America 
bluetongue may be considered endemic). 
BTV can infect red deer generally with mild to none clinical symptoms, however, infected deer 
present both viraemia and seroconversion. Recent studies identified reed deer as a potential reservoir 
of the disease in wildlife. 
Epidemiological roles of wild Artiodactyla (other than ruminants) and wild carnivorous are still 
unclear. 
1.7.3 Endangered species involved 
Neglectable in Lombardy at the moment (potential future risks for lynxes, but unlikely). 
1.8 Potential for silent spread 
1.8.1 Likelihood of recognition due to the clinical symptoms 
Medium in case of acute infections in susceptive hosts, however, symptomatology may vary and 
clinical cases may be show symptoms similar to other diseases. In addition, in several species BTV 
infections can be asymptomatic.  
The name of the disease, bluetongue, originate from the dramatic blood flow disturbances to the 
tongue that may occur in some cases, nonetheless, this sign is not very common (severe infections 
only). 
1.8.2 Spread by subclinical / asymptomatic hosts  
High risk  (mild to asymptomatic in several species). 
BTV can circulate in blood associated to the membrane of red blood cells, and thus, the infection may 
present prolonged viraemia, delayed immune response, and improved transmission during the blood 
meal of the vectors. Cattle are the most important amplifying host because in this species viraemia 
can start 4 days after infection and persist till 60 days (according to OIE recommendations). Moreover, 
cattle do not show symptoms during the infection (except for BTV-8). 
1.8.3 Incubation time 
On average 5 to 10 days (up to 20 days). 
1.9 Variability of the agent 
1.9.1 Species / Types 
One species, several serotypes. 
Bluetongue is caused only by Bluetongue virus, however, BTVs are high variable virus and there are 26 
serotypes known worldwide, including BTV-25 (Toggenburg virus) and BTV-26 (serotype from Kuwait). 
BTV genome consists of 10 strands of double-stranded RNA that codify just as many proteins, 7 of 
these proteins are structural (VP1-7) and the other 3 are non-structural (NS1-3/3a). VP2 and VP5 are 
two highly variable proteins (especially VP2) that determinate viral serotype. Serogroup is manly 
defined by VP7. 
1.9.2 Mutations 
Yes. 
Genetic shift is possible during co-infection with different BTV, reassortment of viral genes may also 
occur between vaccine and wild virus in case of simultaneous infection.  
Genetic drift is possible too and every RNA strand can drift independently. 
1.9.3 Number of hosts / vectors (host-specificity) 
Low host-specificity. 
BTV is able to infect several ruminants species and other Artiodactyla. 
Seroconversion is reported in some African carnivorous. Deadly infections are described in lynxes and 
dogs due to particular conditions. 
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1.10 Knowledge of host-pathogen interaction 
1.10.
1 
Status of knowledge of host-pathogen interaction 
Very good. 
Aspects of the host-pathogen interaction of particular interest:  
− Virus associated with the red cell membrane during viraemia (relevance in epidemiology). 
− Virus infection of endothelium (relevance in virulence). 
− Virus infection of monocytes and host immune response (relevance in diagnosis and 
virulence). 
Some aspects of cellular immunity are not yet clear and need further investigations. 
1.11 Knowledge of immunology 
1.11.
1 
Complete / partial / absent knowledge of humoral immunity 
Almost complete. 
Neutralising antibodies are particularly relevant in humoral immunity because they provide a long-
lasting immunity against BTV infections of the same serotype. However, these antibodies do not 
protect against infection of different serotypes. 
1.11.
2 
Complete / partial / absent knowledge of cellular immunity 
Good. 
Some aspects of cellular immunity are still unclear. 
2 SOCIO-ECONOMIC IMPACT 
2.1 Impact on production within the region 
2.1.1 Production losses  
None in Lombardy, the region is bluetongue-free for the season. 
Production losses may significantly vary due to host species involved and BTV serotype. Economic 
impact of bluetongue can be dramatic in sheep, in cattle the disease is less severe and only BTV-8 may 
cause relevant production losses. 
In cattle BTV-8 can induce both direct and indirect losses. Direct losses: 
− Abortions, stillbirths, malformed calves. 
− Reduced fertility. 
− Reduced milk yield (milking cows) or reduced weight gains (beef cows) 
− Culling of infected animals and related cost (when mandatory because of the control plan) 
Indirect losses: 
− Loss of future income due to the culling of infected animal (particularly during the lactation 
and/or of for high-value bovine). 
− Routine expenses for cow with reduce/no production. 
− Costs of veterinary services (symptomatic therapy and diagnostic) when permitted 
− Ban of animal movements and trades (when present) 
Bluetongue in sheep can cause further losses because of the severity of the disease (morbidity up to 
100% and mortality up to 70%). 
2.1.2 Quality losses 
None in Lombardy, the region is bluetongue-free for the season. 
In case of outbreak: reduced weight gains (beef cows and sheep) and decrease of fleece quality 
(sheep, cutaneous lesions). 
2.1.3 Menace to survival of livestock industry 
None in Lombardy, the region is bluetongue-free for the season (possible risks in the future).  
In Italy, during the firsts years of 2000, over 500,000 sheep were lost (death or culling) and animals 
trades were banned for a long time due to the most severe bluetongue epidemic in the history our 
Country. 
Lack of an efficient surveillance system may permit the introduction of the diseases into a “virgin” 
population and put in danger the related livestock industry. 
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2.2 Economic impact of the control plan 
2.2.1 Voluntary / mandatory control plan 
None (Lombardy is seasonal free). 
2.2.2 Actual cost of the surveillance 
Very Low  (entomological surveillance, sentinel animal, surveillance in slaughterhouses) 
2.2.3 Outbreak within the region (per year) 
None. 
2.2.4 Adopted control measures and actual costs 
Not applicable. 
2.3 Potential economic direct impact 
2.3.1 Production and movement limited / banned 
Ban / limits in animals movements and trade in case of outbreak or area under restriction. 
2.3.2 Potential economic cost 
High. 
In 2006, an epidemic of BTV-8 struck over 400 farms (cattle and small ruminants) in the Netherlands 
and caused economic losses for 32 million of euros; economic cost were distributed as 91% for 
control, 7% for diagnostic, and 2% for treatment. Bovine were the main source of these economic 
losses (88%), particularly milking cows represented the 55% of the costs (highest value per animal). 
In 2007, the epidemic of BTV-8 in the Netherlands spread to over 6,000 farms and economic costs 
were estimated in about 163 – 175 million of euros (92% as production losses); bovine were again the 
main source of these losses (85% of total costs). 
2.3.3 Control strategies available (vaccination and therapy / Test-and-cull / Stamping out) 
At the moment the control is based on identification of areas at risk, vaccination, and ban/limitation 
of animal movements. 
Various control strategies are available: 
− Stamping out and zoning (high costs, low effectiveness). 
− Zoning without vaccination (costs depending on animal trades bans, low effectiveness). 
− Zoning with vaccination of small ruminants only (cost may vary, effectiveness depending on 
number of cattle within the restricted area). 
− Zoning with vaccination of all potential host (cost may vary, good effectiveness if 
immunisation is induced against the correct serotype). 
2.3.4 Costs of intervention (surveillance and control) 
Low for surveillance. In the Netherlands, during the 2006-2007 epidemic, costs of surveillance were 
estimated in about 2 million of euros. 
High for control (culling and zoning). In the Netherlands, during the 2006-2007 epidemic, cost of 
control were estimated in about 22 (2006) and 11 million (2007) of euros. 
2.4 Potential economic indirect impact 
2.4.1 Consequences on the distribution of the products 
Ban of animal movements for long periods in areas where sheep have an important role in local 
economy may lead to both severe financial losses and social tensions, e.g. 2000-2002 epidemic in 
Italy. 
Epidemics of BTV-8 in North Europe during 2006 and 2007 caused relevant negative repercussion on 
products distribution. 
2.4.2 Market value losses 
None indirect. 
Bluetongue is not a zoonosis, and thus, it never leaded to indirect market value losses due to fear fed 
by mass media.  
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2.4.3 Nation-wide ban of distribution 
None.  
Ban within restricted areas (zoning size may vary depending on epidemiological status). 
2.4.4 Cost of treatments and control of the disease in humans 
Not applicable. 
2.4.5 Tourism losses and menace to biodiversity 
None at the moment. 
Potential menace to vulnerable sheep breeds and lynxes. Severe risks in areas (not in Italy) where 
with-tailed deer and pronghorn antelopes are present. 
2.4.6 Restriction on the entire productive system 
Potential risks in case of epidemic in “virgin” populations. At the moment EU laws permit, in particular 
conditions, animal movements even in restricted areas. 
3 IMPACT ON PUBLIC HEALTH 
3.1 Relevance in laws (locals to international) 
3.1.1 Relevance in laws (region / nation / EU / worldwide)  
Not applicable. 
3.2 Zoonotic potential 
3.2.1 Possibility of transmission between animals and humans (yes / no / unclear) 
None (only one case reported due to a laboratory accident). 
3.2.2 Likelihood of transmission between animals and humans 
Not applicable. 
3.2.3 Route of transmission from animals to humans (direct, indirect; vector, food, environment, airborne) 
Not applicable. 
3.2.4 Species barrier 
Not applicable. 
3.2.5 Virulence factors 
Not applicable. 
3.2.6 Likelihood of underestimate human cases 
Not applicable. 
3.3 Likelihood of occurrence 
3.3.1 Probability of occurrence 
Not applicable. 
3.4 Spread in humans 
3.4.1 Likelihood of transmission between humans 
Not applicable. 
3.4.2 Route of transmission between humans (direct, indirect) 
Not applicable. 
3.5 Impact on human health 
3.5.1 Severity of the disease 
Not applicable. 
3.5.2 Symptoms duration and time off work length 
Not applicable. 
3.5.3 Permanent damages 
Not applicable. 
3.5.4 Mortality 
Not applicable. 
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3.6 Impact on food safety 
3.6.1 Likelihood of infection / intoxication due to infected / contaminated food 
Not applicable. 
3.6.2 Infectious / toxic dose 
Not applicable. 
3.6.3 Mandatory precautions 
Not applicable. 
3.7 Bioterrorism potential 
3.7.1 Potential to cause substantial harm in humans 
Not applicable. 
3.7.2 Agent availability 
Not applicable. 
3.7.3 Facility of use and conservation (Labs / trained professionals / sole person) 
Not applicable. 
4 IMPACT ON TRADE 
4.1 Impact on regional trade due to current laws 
4.1.1 Ban / Limitations on trade (positive animal only, herd, limited area, region-wide) 
None at the moment (Lombardy is seasonal free). 
In case of outbreak ban of potential hosts movements (trade and grazing) within the restricted area 
(exception for culling). 
4.1.2 List of banned products 
Semen, eggs and embryos not in compliance with EU standards (Commission Regulation (EC) No. 
1266/2007 and following integrations/modifications). 
4.1.3 Free-status loss 
Yes. At the moment Lombardy is declared seasonal free (in compliance with (EC) No. 1266/2007, 
DGSAFV III/4786 note of 03/13/2009, and DGSAFV 4575 note of 03/12/2010). 
4.1.4 Difficulty and time needed to regain free-status 
High difficulty and prolonged times. 
In order to regain the free status BTV must be absent within the area for at least two years after the 
outbreak (Commission Regulation (EC) No. 1266/2007 and following integrations/modifications). 
4.2 Impact on national / EU trade due to current laws 
4.2.1 Ban / Limitations on trade (positive animal only, herd, limited area, nation-wide) 
Ban and limitations on trade between restricted areas and seasonal-free areas. However, EU laws still 
permit, in particular conditions, animal movements outside restricted areas (Commission Regulation 
(EC) No. 1266/2007 and following integrations/modifications). 
4.2.2 List of banned products 
Semen, eggs and embryos not in compliance with EU standards (Commission Regulation (EC) No. 
1266/2007 and following integrations/modifications). 
4.2.3 Free-status loss 
Not applicable (at the moment Italy is not bluetongue free). 
4.3 Impact on international trade due to current laws 
4.3.1 Ban / Limitations on trade (positive animal only, herd, limited area, nation-wide or EU-wide) 
Ban and limitations on trade may vary (single animal/farm/whole geographical area) depending on 
epidemiological status of the zone, no limitation from free zones (OIE Terrestrial Animal Health Code - 
cap. 8.3). 
4.3.2 List of banned products 
Semen, eggs and embryos not in compliance with OIE standards (OIE Terrestrial Animal Health Code - 
chap. 8.3). 
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4.3.3 Free-status loss 
Not applicable (at the moment Italy is not bluetongue free). 
4.3.5 Countries with particularly strict laws (about the disease) 
None. 
4.4 Potential for zoning 
4.4.1 Zone of control size 
Zoning may vary: 
− In case of suspect: delimitation of an infected zone of 4 km around the farm source of the 
potential threat. 
− In case of confirmation by CESME (Centro Studi Malattie Esotiche): delimitation of a zone of 
control (20 km wide) and a zone of surveillance (entire province). Both these zones may be 
increased or decreased based on vaccination and epidemiological status.   
5 IMPACT ON ANIMAL WELFARE 
5.1 Potential impact on animal welfare (duration) 
5.1.1 Presence and duration of animal welfare damages 
Variable (on average 8 – 10 days). 
BTV infections may vary greatly from asymptomatic forms to acute severe diseases (depending on 
viral serotype, host species, host breed). Severe acute infections can lead to death in 8 – 10 days (48 
hours in peracute cases) or, if the host survive (and not be culled), recovery takes may require 
months. 
5.2 Potential frequency of severe distress 
5.2.1 Percentage of animal with severe distress 
Very high, morbidity up to 100% in some sheep breeds. 
In sheep mortality is usually high and may vary from 30% to 70%; in cattle only BTV-8 is able to induce 
clinical symptoms but mortality is low (< 1%). 
(In white-tailed deer and pronghorn antelopes fatality rate may reach 90%) 
5.3 Severity / reversibility of the disease 
5.3.1 Severity of the disease and reversibility of the damages 
Variable (very high in susceptible hosts). 
Severity of the BTV infections may vary greatly, from asymptomatic infections to severe diseases with 
permanent damages and high mortality. Outcomes of the infection are influenced by BTV serotype, 
host species, and host breed (European sheep breeds, such as Merino, are the most susceptible). 
In sheep: peracute infections induce pulmonary oedema and rapidly lead to death; acute infections 
may cause fever, depression, anorexia, head oedema, dyspnoea, severe blood flow disturbances (skin 
and mucosae), nasal discharge (from serum to pus), excessive salivation, ulcerations, cyanosis, 
haemorrhages, aborts, various gastro-enteric disturbances, foot lesions (hyperaemic coronary bands, 
lameness), and torticollis. 
In cattle: BTV infections are usually asymptomatic, however BTV-8 may induce clinical diseases with 
symptoms similar, but less severe, to sheep infections and low to  no mortality. Moreover, BTV-8 can 
easily infect foetus and can cause cerebral malformation and death. 
In dogs: severe infections of bluetongue had been reported after an accidental contamination of dogs 
vaccines; clinical signs were pneumonia and vasculitis, the fatality rate was very high in pregnant 
bitches. 
5.3.2 Available therapies and their effectiveness 
None. Effective drugs against BTV do not exist, only sustain and symptomatic therapies are available. 
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5.4 Impact on animal freedom 
5.4.1 Potential restriction on the “Five Freedom” (freedom from fear and distress NOT included) 
Potential restrictions to: 
− Freedom from hunger and thirst (erosions and ulcerations in the mouth, atrophy of the 
muscles). 
− Freedom from discomfort (foot lesions, bites from infected midges in absence of control). 
− Freedom from pain, injury or disease. 
− Freedom to express normal behaviour (foot and perineal lesions). 
6 CONTROL TOOLS 
6.1 Proper tools for diagnosis 
6.1.1 Validated kits availability within the nation  
Experimental Zooprophylactic Institute of Lombardy and Emilia Romagna (IZLER) provide the following 
diagnostic services: 
− PCR qualitative and real-time PCR; 
− Competitive ELISA (VMRD kit); 
− Competitive ELISA (IZSAM kit); 
− ELISA for antibodies in serum or milk (ID VET kit). 
6.1.2 Laws that rule the surveillance 
Surveillance plan, tools for diagnosis, and outbreaks identifications must be in compliance with EU 
laws (Council Directive 2000/75/EC of 20 November 2000, Commission Regulation (EC) No. 
1266/2007, and following integrations/modifications). 
6.1.3 Techniques described by international organisation (OIE, WHO, UE, etc.) 
OIE MANUAL OF DIAGNOSTIC TESTS AND VACCINES FOR TERRESTRIAL ANIMALS (Chap. 2.1.3): 
 
d) Identification of  BTV 
− Virus isolation (from blood or other tissues, prescribed tests for international trade):  
o Isolation in embryonated hens’ eggs (about 1 week required for identification, good 
sensitivity but complicated). 
o Isolation in cell culture (about 5 days but low sensitivity). 
o Isolation in sheep (up to 28 days, most sensitive technique but also most costly). 
− Immunological methods:  
o Identification of serogroup (immunofluorescence, antigen capture enzyme-linked 
immunosorbent assay, immunospot test). 
o Identification of serotype (virus neutralisation). 
− Polymerase chain reaction techniques: 
o Reverse-transcription polymerase chain reaction (prescribed tests for international 
trade), fast and sensitive but risks of false positive due to contamination (by other 
samples or primers) and false negative due to incorrect sampling or wrong primers. 
o Real-time reverse-transcription polymerase chain reaction tests (not yet validated). 
 
e) Serological tests 
− Complement fixation (outdated since 1982) 
− AGID (an alternative test for international trade): problems due to low specificity (detect 
both anti-BTV and anti-EHDV antibodies) and subjectivity exercised in reading the results. 
− ELISA techniques: 
o Competitive ELISA (an alternative test for international trade), fast and good 
specificity. 
o Indirect ELISA (bulk milk), only for surveillance purposes. 
6.1.4 DIVA test possibility / obligation of use  
None 
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6.1.5 Overall judgement on tools for control 
Tools for surveillance and control in compliance with EU standard are considered effective for safe 
trades of sensible animal species, semen, eggs and embryos. 
Vaccination provide a strong and effective immunity against BTV. However, vaccination presents also 
relevant drawbacks such as: risks of severe adverse reaction, reassortment between vaccine and wild-
type BTV, reversion to virulence and infections in unvaccinated animals, absence of cross-protective 
immune response against different serotypes (introduction of a diverse wild-type BTV serotype within 
a population may lead to an epidemic). 
Lombardy region, at the moment, is a low-risk region, nonetheless, an effective surveillance plan is 
still pivotal. Several areas within the region provide favourable climate and ecology for Culicoides spp. 
seasonal activities (feeding and mating). Moreover, the wind may transport infected midges from 
high-risk area to Lombardy and increase the level of risk in the region (particularly if a new serotype is 
introduced in Italy). 
6.2 Proper tools for prevention (within the region/area) 
6.2.1 Obstacles / incentives to prevention 
Obstacle: control of the vectors may be difficult, frequent animal movements (trade and grazing), high 
densities of potential hosts and farms, unclear epidemiological role of wildlife, illegal trade of 
potential hosts in region (from high-risk areas), introduction of new serotypes in Italy. 
Incentives: surveillance and prevention are essential in bluetongue control, EU incentives and grants, 
prevention of an outbreak prevent also economic losses due to the diseases and ban of animal 
movements. 
6.2.2 Available prevention strategies and their efficacy 
Various strategies can be adopted: high levels of biosecurity, control of the vectors, and surveillance. 
Namely, control of animal movements, reduction of contacts between amplifying and sensitive hosts, 
vaccination, control of semen and embryos, insecticides and midges repellents (temporary effective 
only), protection of the potential hosts during the hours of midges activities (midges net). 
Various strategy for surveillance are available and can be used in association (combinations may vary 
depending on epidemiological status): 
− Clinical surveillance: all the suspect cases must be reported. 
− Serological surveillance: sentinel animals (usually cattle); single animals tested on farm and 
slaughterhouse, bulk milk tests. 
− Entomological surveillance: fixed and mobile traps to verify presence, diffusion, seasonal 
cycles, and infective status of potential vectors. 
− Virological surveillance: Virus isolation and typing. 
6.2.3 Commercial vaccines availability in EU / Worldwide 
Several vaccines, attenuated or killed, are available within EU and Worldwide. Additionally, 
recombinant vaccines are under development. 
6.2.4 Marker vaccines availability in EU / Worldwide 
None. 
6.2.5 Vaccination efficacy 
Vaccination presents both advantages and disadvantages. 
Advantages: strong and prolonged immunity that provide protection against clinical disease 
(especially modified live vaccines [MLV]), massive vaccination of both cattle and small ruminants is 
possible, mixture of different serotypes available, relatively easy integration into a control plan, may 
be simplify animal trade. 
Disadvantages: relatively common adverse reaction (0.1% in cattle and 0.5% in small ruminates but 
overestimated according some Authors), absence of cross-protective immune response against 
serotypes different from vaccine ones, risks of reassortment between vaccine and wild-type BTV (risks 
can be significantly lowered if vaccination is not provided during the seasonal activities of the 
vectors), infections of MLV in unvaccinated animals (risks can be significantly lowered if vaccination is 
not provided during the seasonal activities of the vectors), in MLV risks of excessive/inadequate 
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attenuation (protective cellular immune response is proportional to BTV replication within the host), 
reversion to virulence (unlikely for some Authors). In addition, some problems may arise due to the 
presence of only one producer of BTV vaccines in Italy (natural monopoly, supply shortages). 
6.2.6 Laws that rule vaccination 
Compulsory vaccination, in case of zoning, in compliance with Italians and EU laws (Commission 
Regulation (EC) No. 1266/2007, DGSAFV III/4786 note of 03/13/2009, DGSAFV 4575 note of  
03/12/2010, and following integrations/modifications). 
Lombardy region is seasonal free, the last mandatory vaccination campaign was in Mantova province 
during 2009 due to an outbreak of BTV-8 in Veneto region (“decreto direzione generale sanità n. 7209 
del 02/07/2008”). 
6.3 Proper tools for control (within the region/area) 
6.3.1 Obstacles / Incentives to control 
Obstacle: control of the vectors may be difficult, frequent animal movements (trade and grazing), high 
densities of potential hosts and farms, unclear epidemiological role of wildlife, illegal trade of 
potential hosts in region (from high-risk areas), introduction of new serotypes in Italy. 
Incentives: mandatory control plan, EU incentives and grants, extinguish of an outbreak prevent 
future economic losses due to the diseases and stops the ban of animal movements. 
6.3.2 Available control strategies and their efficacy 
Various strategies can be adopted: high levels of biosecurity, control of the vectors, and a control 
plan. 
During the last 15 years different control strategies, based on zoning, were proposed such as: 
stamping out, modified stamping out, vaccination, or ban of potential hosts movements. However, 
these strategies, when used alone, showed poor effectiveness. 
The actual control system encompasses a surveillance plan (epidemiological and entomological) and 
control measures in case of outbreak, such as zoning (area under control + area under surveillance) 
and massive vaccination of potential hosts (domestic species only). This approach provide good 
effectiveness when used to control a known serotype but it has some limits. Indeed, vaccination do 
not provide cross-immunity against different serotypes and vectors, harbouring a diverse serotype, 
may be transported by wind from neighbour Mediterranean Countries where effective surveillance 
systems are not present. 
Lombardy, at the moment, is seasonal free and a low-risks zone, nonetheless, this scenario may 
change in future because of several areas within the region provide, during the warm season, 
favourable environment for Culicoides spp.. Therefore, maintaining an effective surveillance system is 
essential. 
6.3.3 Laws that rule control strategy 
Control tools must be in compliance with EU laws (Council Directive 2000/75/EC of 20 November 
2000, Commission Regulation (EC) No. 1266/2007, and following integrations/modifications). 
6.4 Proper tools for therapy 
6.4.1 Therapeutic protocol in use (cure and prophylaxis) 
Effective drugs against BTV do not exist. Only sustain therapies, vaccines, and midges repellent are 
available.  
6.4.2 Laws that rule therapies 
Not applicable. 
6.4.3 Residual risks / suspension time 
Not applicable. 
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Risk Prioritization as a Tool to Guide Veterinary Public Health Activities at Regional Level 
Authors: Scali F.1, Bonizzi L.1 , Ferrari N.1, Ferrero F1, Frazzi P.2, Grilli G.1, Lanfranchi P.1, 
Mortarino M.1, Sala V1, Taloni D1 & Zecconi A.1 
 
Veterinaria Italiana 2014, accepted, in press 
(1)  Dipartimento di Scienze Veterinarie e Sanità Pubblica (DIVET), Università degli Studi di Milano, Via 
Celoria 10, 20133 Milan, Italy  
 (2) Unità Organizzativa Veterinaria, Regione Lombardia, via Pola 9-11, 20124 Milan, Italy 
 
Abstract 
A model for prioritization and risk characterization focused on zoonosis and food safety was 
developed for diseases of interest in veterinary public health at a regional level. A previous model 
(DISCONTOOLS) based on scorecards was used as a basis to develop the new one . Formalized 
Consensus Process approach involving academics and veterinary officers was used to develop form, 
scorecards and relative guide. Scorecards were filled following available data, literature and expert 
opinions. A scorecard with maximum theoretical score of 1,000 was developed; it includes several 
areas of interest, with different categories and coefficient of importance. The following areas were 
identified: relevance of the disease, socio-economic impact, impact on public health, impact on 
trade, impact on animal welfare, control tools. A guide and a form were settled in order to fill the 
scorecard. From an initial list of 38 disease, 23 were scored. Among bovine diseases mastitis (S. 
aureus) showed the highest score; among small ruminants Query fever was the highest, among 
swine diseases the highest was salmonellosis, while among other animal diseases  toxoplasmosis 
had the highest score. 
This approach is conceived to aid professionals in risk prioritization, decision-making and to 
improve disease control systems at a regional level. It also allows to perform risk characterization in 
different backgrounds and to identify lacks of data in specific areas of interest for the diseases 
considered. 
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Staphylococcus aureus virulence factors in evasion from innate immune defenses in human 
and animal diseases. 
Authors: Zecconi A. 1 & Scali F. 1 
Immunology Letters 2013 Feb;150(1-2):12-22. doi: 10.1016/j.imlet.2013.01.004. Epub 2013 Jan 
31. 
(1)  Dipartimento di Scienze Veterinarie e Sanità Pubblica (DIVET), Università degli Studi di Milano, Via 
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Abstract 
In the last decades, Staphylococcus aureus acquired a dramatic relevance in human and veterinary 
medicine for different reasons, one of them represented by the increasing prevalence of antibiotic 
resistant strains. However, antibiotic resistance is not the only weapon in the arsenal of S. aureus. 
Indeed, these bacteria have plenty of virulence factors, including a vast ability to evade host 
immune defenses. The innate immune system represents the first line of defense against invading 
pathogens. This system consists of three major effector mechanisms: antimicrobial peptides and 
enzymes, the complement system and phagocytes. In this review, we focused on S. aureus virulence 
factors involved in the immune evasion in the first phases of infection: TLR recognition avoidance, 
adhesins affecting immune response and resistance to host defenses peptides and polypeptides. 
Studies of innate immune defenses and their role against S. aureus are important in human and 
veterinary medicine given the problems related to S. aureus antimicrobial resistance. Moreover, due 
to the pathogen ability to manipulate the immune response, these data are needed to develop 
efficacious vaccines or molecules against S. aureus. 
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How are important targets in development of S.aureus mastitis vaccine? 
Authors: Scali F. (1), Camussone C. (2), Calvinho L.F. (2) & Zecconi A. (1) 
(1) Dipartimento di Scienze Veterinarie e Sanità Pubblica (DIVET), Università degli Studi di Milano, Milan, 
Italy  
(2)  Istituto  Nacional de Tecnologia Agropecuaria, Rafaela Argentina 
Research in Veterinary Sciences (submitted) 
Staphylococcus aureus represents one of the leading causes of mastitis in dairy cows worldwide. In 
cattle, S. aureus intramammary infections (IMI) may entail severe economic losses even without 
clear clinical signs. S. aureus IMI have variable outcomes due to virulence of the strain involved, 
immune defences of the host, different management choices, and environmental conditions. 
Management and environment can also induce selective pressure on S. aureus and amplify 
differences among farms. Furthermore, S. aureus IMI may pose a threat to public health as potential 
source of food poisoning or methicillin-resistant S. aureus (MRSA). S. aureus infections can be 
exacerbated by its several virulence factors and its ability to resist to many antibiotics. All these 
characteristics facilitate the onset of chronic mastitis and a successful treatment during milking is 
unlikely. Therefore, infected cows have improved cure rates during the dry period, otherwise, they 
should be culled. Improvements of management and udder health seem to have reduced prevalence 
of S. aureus IMI in several countries but the pathogen is still widespread and eradication, at this 
point, is improbable. The difficulty in eradication and the increasing concerns on antibiotics usages 
underscore the interest in developing new tools to control S. aureus mastitis. Over the last 40 years, 
vaccination has represented one of the most studied of these tools but, to date, no vaccine seems to 
provide reliable protection. This review will summarize current knowledge on the major vaccine 
targets, including surface proteins, capsular polysaccharides, biofilm, and toxins. Finally, we will 
discuss the present status of vaccination against S. aureus and the future of vaccines designs, 
including how difference among in vivo models may  influence vaccines development. 
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Pattern characterization of genes involved in non-specific immune response in Staphylococcus 
aureus isolates from subclinical mastitis 
 
Authors: Mazzilli M. (1),  Piccinini R. (1),  Scali F. (1) & Zecconi A. (1) 
Research in Veterinary Sciences (submitted) 
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Abstract 
Staphylococcus aureus isolated from mammary gland are characterized by different genetic 
patterns, and this variability is behind the differences observed in both clinic and economic aspects 
of these infections. These bacteria have an impressive arsenal of virulence factors which facilitate 
invasion, improve adhesion to the host, promote immune evasion and impairs host defences. Ninety 
four isolates from 33 dairy herds were analyzed by the means of a   microarray to investigate S. 
aureus virulence patterns and, in addition, the role of genes specifically involved in immune 
evasion. None of the 94 isolates considered were MRSA. However, 50% of the isolates belonged to 
complexes related to MRSA and to human diseases (CC1, CC5, CC8, CC20, CC398), while only 
about 25% of them can be considered as exclusively of bovine origin. The distribution of clonal 
complexes and the different gene patterns observed confirmed the presence of an influence of 
geographical localization, which has important implications both from S. aureus epidemiology and 
prevention. 
The assessment of the influence of genes related to immune evasion on quarter milk cell count 
(SCC) gave some unexpected results. A  low frequency of enterotoxin genes was observed, 
supporting the hypothesis that enterotoxins did not play a major role in bovine mastitis 
pathogenesis. Among the other genes, four of them (ssl7, ssl11, chip and cap8) showed to be 
significantly associated to an increase quarter milk SCC. These genes could be potential target for 
developing new vaccines against S. aureus. 
